Congress of the International Society on Thrombosis and Haemostasis

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

H
Haas SK	-	Prevention of Venous Thromboembolism with Low-Molecular-Weight Heparin in Patients with Metastatic Breast or Lung Cancer – Results of the TOPIC Studies
Haas F	-	The Clinical Probability Score and D-dimers Are Not Recommended in Elderly Patients Suspected for Having Deep Vein Thrombosis
Haas SK	-	Prevention of Venous Thromboembolism with an Oral, Direct Factor Xa Inhibitor – BAY 59-7939 – in Elective Hip Replacement: A Dose-Ranging Study
Haas F	-	Stable Plasma D-dimer Concentrations after Prolonged Freezing
Haas FJLM	-	Fibrin Monomers in the Diagnosis of Deep Vein Thrombosis
Haas S	-	Fatal Vascular Outcomes Following Major Orthopedic Surgery
Haas A	-	Lipoprotein Pattern in Patients with Retinal Artery Occlusion or Retinal Vein Occlusion
Haas TA	-	A Cytoplasmic Template for the Development of Beta3 Drug Therapeutics
Haasnoot K	-	Congenital Deficiency of Factor XIII Caused by Two Missense Mutations in a Dutch Family
Habart D	-	Two Novel Type 1 Von Willebrand Disease Causing Mutations (G160W and N166I) in the Von Willebrand Factor Propeptide, Identified in the European Study MCMDM-1VWD, Are Responsible for Multimerization And Secretion Defects
	-	A Reduced VWF to FVIII Binding Capacity is not Uncommon in Patients With Type 1 Von Willebrand Disease: Results From the MCMDM-1VWD Study
	-	Association of FVIII/Von Willebrand Factor Measurements and PFA-100® with Bleeding Score in Type 1 Von Willebrand Disease (VWD) Families. The MCMDM-1 Study
	-	Multimer Pattern in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
	-	In vitro Expression of Ten Missense Mutations in the VWF C-Terminal Domain Identified in Patients Diagnosed with Type 1 VWD: Results from the MCMDM-1VWD Study
	-	Eight Novel Mutations in FXI Gene
	-	Cysteine Mutations in the von Willebrand Factor D3 Domain Correlate with Multimerization Defects in Patients Previously Diagnosed with von Willebrand Disease Type 1 in Patients Entered in the European Multicentre Study MCMDM-1VWD
	-	Linkage Analysis of von Willebrand Disease Type 1 Phenotype, von Willebrand Factor Levels and Bleeding Symptoms with Von Willebrand Factor Gene Locus in the European Multicenter MCMDM-1VWD Study
	-	Abnormal Multimeric Pattern Is Not Associated with Increased Bleeding Symptoms in Index Cases of Families with Type 1 VWD. Results from the EU MCMDM-1 VWD Study
	-	Responsiveness to Desmopressin: Influence of Genotype in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD
	-	Assay of the von Willebrand Factor Propeptide (VWFpp) to Identify Type 1 von Willebrand Disease (VWD) Patients with a Decreased von Willebrand Factor (VWF) Survival Phenotype
	-	The Incidence and Penetrance of Common VWF Gene Mutations in a Cohort of Type 1 VWD Patients: Results from the EU Funded MCMDM-1VWD Project
	-	The Factor VIII/von Willebrand Factor Antigen (FVIII/VWF : Ag) Ratio in Determining VWF Defects in Patients with von Willebrand Disease Type 1: Results from the European Multicenter MCMDM-1VWD Study
	-	Collagen Binding (VWF : CB) Is Less Sensitive Than Ristocetin Cofactor Activity (VWF : RCo) in Suggesting Von Willebrand Factor (VWF) Molecular Defects in Patients with Von Willebrand Disease Type 1: Results From the European Multicenter MCMDM-1VWD Study
	-	Analysis of Bleeding Score in Type 1 VWD Families in the MCMDM-1 Study
Haberichter SL	-	Assay of the von Willebrand Factor Propeptide (VWFpp) to Identify Type 1 von Willebrand Disease (VWD) Patients with a Decreased von Willebrand Factor (VWF) Survival Phenotype
Haberichter S	-	Normal VWF Synthesis and Processing in Patients with Decreased Plasma Survival of C6536T Variant VWF
Hack CE	-	P-selectin- and CD63-Exposing Platelet Microparticles Reflect Platelet Activation in Peripheral Arterial Disease and Myocardial Infarction
Hack C	-	Plasma Levels of PAI-1 and Risk of Death from Dengue: No Association with the 4G/5G Promoter Polymorphism
Hack CE	-	Complement Activation on the Surface of Cell-Derived Microparticles in Rheumatoid Arthritis
	-	Serum Levels of Soluble Tissue Factor and the Risk of Future Coronary Artery Disease; The EPIC-Norfolk Prospective Population Study
	-	Activation of the Contact Factor System and Its Predictive Role in Coronary Heart Disease and Ischemic Stroke; Follow Up from the Second Northwick Park Heart Study
Hackeng TM	-	C4b-binding Protein (C4BP) Prolongs the Survival of Human Protein S in an Experimental Mouse Model
Hackeng T	-	Intracellular PAR Antagonists Have Anticoagulant and Antithrombotic Properties
Hackeng TM	-	Effect of Oral Contraceptives on the Anticoagulant Activity of Protein S in Plasma
Hackeng T	-	Down-regulation of Tissue Factor Surface Expression by Annexin A5: a New Anticoagulant Mechanism
Hadders M	-	Determination of Interacting Residues within the VWF A3-Domain and the Antithrombotic Antibody 82D6A3 by Docking, Cocrystallisation and Mutagenesis
Hadj-Ali A	-	Prolonged Extracorporeal Life Support (ECLS) in Patients with Severe Membrane Stabilizing Agent (MSA) Poisonings: Hemostatic Management Requires only Minimal Doses of Heparin
Hadjar E	-	The Relationship Between Hypercoagulable State and Sudden Sensory Neural Deafness
Hadley A	-	Modified Human Recombinant HPA-1a Antibodies Inhibit Platelet Binding and Monocyte Activation by Polyclonal Anti-HPA-1a Sera
Haeberli A	-	Variation in Coagulation Inhibitors During Prolonged Sitting: Possible Pathogenetic Mechanisms for Travel-associated Thrombosis
Haertel S	-	Use of Helixate^®NexGen in the Treatment of Patients with Haemophilia A: A Long-Term Pharmacovigilance Surveillance
Hafizi S	-	Analysis of Gas6 in Human Platelets and Plasma
Hafner G	-	Multicenter Evaluation of BCS^® XP – A Further Development of the Widespread BCS^® Coagulation Analyzer
	-	Performance Evaluation of APC Resistance/FV Leiden Assay Applications on Routine Coagulation Analyzers
Hagedorn A	-	Anticoagulant Effects and Inhibition of Thrombin Generation in Patients on Ximelagatran
	-	Inhibition of Thrombin Generation by Warfarin
	-	Anticoagulant Effects of Idraparinux Compared to Fondaparinux and Dalteparin
Hageman G	-	Plasma Ecto-NTPDase Prevents Platelet P2X₁ and P2Y₁₂ Receptor Desensitization During Storage
Hagemeyer CE	-	Targeting of the Direct FXa Inhibitor TAP via the Fusion of a Single-chain Antibody Directed Against a LIBS Epitope on GPIIb/IIIa Provides Effective Anticoagulation without Bleeding Time Prolongation
Hagg D	-	Resuscitation with Lactated Ringers (LR) vs. Normal Saline (NS) Leads to a Hypercoagulable State in an Uncontrolled Hemorrhagic Shock Swine Model
Hagger D	-	Use of Rituximab in Acute Refractory Thrombotic Thrombocytopenic Purpura
Haghighi N	-	Venous Function and Clinical Outcome Following Deep Vein Thrombosis
	-	Risk Factor Assessment in the Management of Patients with Suspected Deep Venous Thrombosis
Hagihara K	-	Active Metabolites of CS-747 (Prasugrel, LY640315) and Clopidogrel Show Similar in vitro P2Y₁₂ Receptor Blockade But Greater in vivo Potency of CS-747
Hagiwara N	-	Aspirin-Resistant Thromboxane Biosynthesis in Patients with Coronary Artery Disease; Role of Systemic Inflammation and Glycemic Control
Hagiwara H	-	Induction of Renal PAI-1 Gene Expression in a Rat Model of Type-2 Diabetic Nephropathy and Role of Albumin in PAI-1 Induction
Hague W	-	Are High Factor VIII Levels in Combination with High Fibrinogen Levels a Consistent Finding in Compromised Obstetric Cases Particularly Preeclampsia?
Hahn CN	-	Expression Profiling Reveals Functionally Important Genes and Coordinately Regulated Signalling Pathway Genes During in vitro Angiogenesis
Haj[scaron]manová Z	-	Syndrome Kasabach-Merritt and Severe Postoperative Bleeding
	-	The Monitoring FEIBA Therapeutic Effect in a Haemophiliac with an Inhibitor by the Method of Thrombelastography
Haj[scaron]manová Z	-	Special Hemocoagulative Examination at Invasive Meningococcal Disease
Hakobyan N	-	Synovitis in a Murine Model of Human Factor VIII Deficiency: Pathology and the Molecular Basis of Disease
Halawani S	-	Evaluation of Aspirin Resistance in Peripheral Arterial Disease
Halder C	-	Mutation Profile in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
Halimeh S	-	High Levels of Lp(a) in Complicated Pregnancies and Women with Recurrent Fetal Loss and Successful Treatment with Dalteparin
	-	A Case of Pseudotumor Cerebri in a Patient with Thrombophilia
Halimeh S	-	Low Heparin (Dalteparin) as a New Treatment for Ophthalmological Arterial-Venous Vessels Occlusion
Hall L	-	Genetic Variation of VWD Type I in Sweden: Tracing the Evolutionary History of the von Willebrand Factor Gene Region
Hall AJ	-	Functional Analysis of A -13 G/A Dimorphism at the Major Transcription Initiation Site of the Protein Z Gene
Halldén C	-	Large Deletions Explain Protein S Deficiency in Many Cases Where Previous Mutation Detection Has Failed
	-	Genetic Variation of VWD Type I in Sweden: Tracing the Evolutionary History of the von Willebrand Factor Gene Region
	-	The Haplotype Structure of the von Willebrand Factor (VWF) Gene Promoter Indicates Balancing Selection
	-	Co-segregation of the PROS1 Locus and Protein S Deficiency in Families having no Detectable Mutations in PROS1
Halona M	-	Successful Use of FEIBA to Control Postoperative Bleeding after Use of rFVIIa
Hamacher J	-	Early Anticoagulation for Prevention and Therapy of Deep Venous Thrombosis In Patients Undergoing Craniotomy For Brain Tumor – Risk of Postoperative Intra-cranial Hemorrhage in a Prospective Long-term Study
	-	Perioperative Prophylaxis Against Thromboembolism in Patients Undergoing Craniotomy for Brain Tumor: Analysis of Efficacy of Early Low Molecular Weight Heparin
Hamaguchi N	-	Characterization Of Factor IX With Mutations At Residues 190 And 192 Of The Heavy Chain Of Defective Factor IX Found In Patients With Hemophilia B
Hamaguchi M	-	In vitro Characterization of Increased Factor V 1 Form by Factor V R2 Haplotype
Hamaia S	-	Functional Evidence for Three I-domain Activation States for Platelet a2b1 Integrin
Hamato N	-	Purification and Characterization of Recombinant Antithrombin Expressed in Chinese Hamster Ovary Cells
Hamdy M	-	Soluble P-Selectin Levels in Diabetes Mellitus Patients with Coronary Artery Disease
Hamilton JR	-	Maximal Platelet Accumulation, But Not Fibrin Deposition, Is Dependent on Protease-Activated Receptor 4 in a Mouse Model of Thrombosis
Hammer F	-	Angiographic Documentation of the Efficacy of Recombinant Activated Factor VII (Novo Seven) to Control Diffuse Bleeding in Major Trauma
Hammerstingl C	-	Thromboembolic Risk Adapted Dosage of Low Molecular Weight Heparin in Chronically Anticoagulated Patients with Atrial Fibrillation Prior to Interventions with High Risk of Bleeding: Experience in 400 Patients
Hammerstrøm J	-	Anticardiolipin Antibodies and Risk for Venous Thrombosis in a Population-Based Prospective Study
Hampton KK	-	Haemoperitoneum Associated with Ovulation in Women with Autosomal Recessive Bleeding Disorders
	-	Clinical Use of Protamine for the Emergency Reversal of Anticoagulation with Low Molecular Weight Heparin (LMWH)
Hamulyak K	-	Absolute Risk of Venous and Arterial Thromboembolism Associated with Mild Hyperhomocysteinemia. Results from a Retrospective Family Cohort Study
	-	Activation of the Contact Factor System and Its Predictive Role in Coronary Heart Disease and Ischemic Stroke; Follow Up from the Second Northwick Park Heart Study
Hamulyák K	-	A Prospective Cohort Study of Asymptomatic Individuals with Elevated Factor VIII : c to Determine the Absolute Incidence of Venous and Arterial Thromboembolism
Hamulyak K	-	The Contribution of Cosegregation to the Absolute Risk of Venous Thromboembolism (VTE) in Relatives with Either the Prothrombin G20210A Mutation, High Factor VIII : C Levels or Mild Hyperhomocysteinemia
Hamulyák K	-	Absolute Incidence of Recurrent Venous Thromboembolism in Patients with Elevated Levels of Factor VIII : c
	-	Plasminogen Activator Inhibitor-1 Plasma Levels Increase after Myocardial Ischemia/Reperfusion Injury in Mice
Hamulyak K	-	Soluble Tissue Factor: A Marker of Microvascular Disease in Patients with Type 2 Diabetes
Hamulyák K	-	Changes in Fibrinolysis Activity after Angiotensin II Receptor Blockade in Patients Undergoing Renal Artery Angiography
Hamulyak K	-	Activity and Localization of Tissue Factor and Factor VII in Organs of Normal and Endotoxemic Mice
Hamulyák K	-	ASIS Blocks Tissue Factor Activity in the Heart after Ischemia/Reperfusion Injury in Mice
	-	Incidence of Venous and Arterial Thromboembolism in Asymptomatic Carriers of the Prothrombin 20210A Mutation – A Prospective Cohort Study
Hamulyak K	-	Laboratory Markers of Cardiovascular Disease in Systemic Lupus Erythematosus: Evidence of a Latent Hypercoagulable State
Han JH	-	Thymidylate Synthase Enhancer Region (TSER) Is a Novel Genetic Determinant of Hyperhomocysteinemia in Ischemic Stroke Patients
Han Y	-	Increased Plasma and Platelet Surface Fibronectin in Acute Myocardial Infarction Patients
Han J	-	Inhibitory Effects of Tirofiban on Platelet Function in Korean Patients During Percutaneous Coronary Intervention
	-	Acute Inhibitory Effects of Glycoprotein IIb/IIIa Receptor Blockers on Platelet Function During Percutaneous Coronary Intervention
Han F-Y	-	The Impact of Factor XIII Polymorphisms, FXIIIa T204P, P506L and Factor XIIIb Polymorphism H95A, on Myocardial Infarction
Handa M	-	The Rap1 Activation Mechanism in Platelets: It is Related to the Release Reaction Mediated Through the Collagen Receptor Glycoprotein (GP) VI
	-	Hemostatic Effects of Polymerized Albumin Particles Carrying Fibrinogen-g Chain Dodecapeptide as Platelet Substitutes in vitro and in vivo
	-	Platelet aIIbb3 Integrin Constrained in the Extended Conformer Represents an Highly Activated Form
	-	Hemostatic Effects of Polymerized Albumin Particles Carrying Recombinant Glycoprotein Iba as Platelet Substitutes in vitro and in vivo
	-	Signaling Mediated by Glycoprotein Ib-IX-V/VWF Interaction Mainly Takes Place in GEMs In Human Platelets
Handler S	-	Evaluation of the Automated Coagulation Analyzer ACL TOP^TM
Hanfland P	-	Usefulness of a Particle Gel Immunoassay (PaGIA) for Rapid Diagnosis of Heparin-Induced Thrombocytopenia
Hankey GJ	-	Enhanced Antiplatelet Effect of Clopidogrel in Patients with Aspirin Resistance: A Randomized Crossover Trial
	-	Protein Z Gene Polymorphisms, Protein Z Concentration and Ischaemic Stroke
	-	Preventable Stroke and Stroke Prevention
Hanley JP	-	Recombinant Factor VIIa in the Management of Major Haemorrhage: Use of a Prognostic Scoring System Can Help to Predict Outcome
Hann A	-	Preliminary Results of a Cross-Sectional Study of Mild Hemophilia A in Newfoundland and Labrador, Canada
Hansen J	-	Regulation of CD154 (CD40L) and CD62 (p-selectin) Cell Surface Density May Be a Critical Mechanism in Conferring Proinflammatory and Prothrombotic Effects
Hansen JB	-	Effects of Heparins on the Anticoagulant Function of Endothelial Tissue Factor Pathway Inhibitor (TFPI)
Hansen HR	-	Laboratory Markers of Cardiovascular Disease in Systemic Lupus Erythematosus: Evidence of a Latent Hypercoagulable State
Hansen JB	-	Serum Osteoprotegerin in Young Survivors of Myocardial Infarction
Hansen JB	-	Increased Formation of Platelet-derived Microparticles by Heparin
	-	Heparin Induces Release of Osteoprotegerin (OPG)
Hansen JB	-	Increased Coagulation Activation in Persons with Echogenic Carotid Plaques
Hansen L	-	Measurement of Von Willebrand Activity Using an Automated Latex Agglutination Technique Adapted for Use on the STA-Compact Coagulation Analayser
Hansen H	-	Impaired Thrombus Formation after Sterile Inflammation Induced by Endotoxin in a Murine Carotid Artery Thrombosis Model
Hansen HR	-	Soluble Tissue Factor: A Marker of Microvascular Disease in Patients with Type 2 Diabetes
Hanslik A	-	Diagnosis of Central Venous Line-Related Thrombotic Events in the Upper Venous System in Children: Combination of Venography, Venous Ultrasound, and Echocardiography
Hanslik A	-	No Major Impact of Prothrombotic Conditions on The Risk of Central Venous Line-Related Thrombotic Events in Children
Hanson SR	-	Prolonged Anticoagulation and Sustained Therapeutic Endogenous Activated Protein C (APC) Levels during Protein C Activation in Primates by a Thrombin Variant
Hanss MML	-	Fibrinogen Variants of the Gamma Chain Coiled-Coil Portion Detected by Reverse Phase HPLC in Patients with Venous Thrombosis
Hanss M	-	Intracerabral Hematoma and Congenital Afibrinogenemia
	-	Usefulness of Thromboelastography (ROTEM) for Treatment Management in a Severe Deficiency FXIII Patient with Inhibitor
Hansson K	-	Analysis of Gas6 in Human Platelets and Plasma
Hansson S	-	Expression of ADAMTS13 in Normal Renal Cortex and in Thrombotic Thrombocytopenic Purpura
Hantson P	-	Angiographic Documentation of the Efficacy of Recombinant Activated Factor VII (Novo Seven) to Control Diffuse Bleeding in Major Trauma
Hao X	-	Therapeutic Endogenous Ligand/Receptor Induction of the VEGF-Angiopoietin System after Intramyocardial Gene Transfer during Myocardial Ischemia
Haond C	-	Apaf-1 and Caspase 9 Regulate Early and Late Stages of Megakaryocyte Differentiation
Haque W	-	Novel Dual-Action Anti-Platelet/Anti-Thrombotic Drugs for the Management of HIT
	-	Biochemical and Pharmacologic Profiling of a Novel Dual Acting Antithrombin Agent with Antiprotease and Antiplatelet Actions
	-	Comparative Anticoagulant Effects of a Synthetic, Dual Antithrombotic/Antiplatelet Agent, CanAm 208, with Argatroban and Angiomax
Harada N	-	Antithrombin Failed to Attenuate Inflammatory Responses in Congenital Calcitonin Gene-Related Peptide Deficient Mice Subjected to Hepatic Ischemia/Reperfusion
Harari G	-	Evaluation of Pro-angiogenic and Pro-Coagulant Activity of Irradiated, Non Irradiated and Filtered Stored Blood Used in Transfusion Practice
Harbeck N	-	Analysis of the Differential Expression of uPA, PAI-1, and Tissue Kallikreins hk5, 6, 7, 8, 10, 11, 13 between Primary Ovarian Carcinoma Tissues and Corresponding Omentum Metastases
Harbeck-Seu A	-	Gene Conversions Are a Common Cause of von Willebrand Disease
Harbour SN	-	The Palmitolyated Cysteine 595 Residue of PECAM-1 Is Required for Constitutive Association of PECAM-1 into Membrane Microdomains
Harbrecht U	-	Usefulness of a Particle Gel Immunoassay (PaGIA) for Rapid Diagnosis of Heparin-Induced Thrombocytopenia
Hardikar W	-	Multi Modal Management of Purpura Fulminans due to Homozygous Protein C Deficiency
	-	Chromogenic and Clot Based Protein C Assays Contribute to the Management Of Homozygous Protein C Deficient Patients
Harding K	-	A Novel P-Selectin Inhibitor, PSI-697, Demonstrates Positive Activity Following Oral Administration in Rodent Models of Vascular Inflammation
Hardy AR	-	Regulation of Platelet P2Y₁ and P2Y₁₂ Purinergic Receptor Internalization
Hardy K	-	Heparin Has Variable Effects on the Release of Glycosylphosphatidylinositol-Lipid Anchored TFPI from Human Umbilical Vein Endothelial Cells
Harenberg J	-	Safety and Efficacy of Low-Molecular-Weight Heparin (Dalteparin) in Pregnant Women at Increased Risk of Venous Thromboembolism: A Prospective Stratified Multicentre Trial
Harenberg J	-	Prophylaxis of Thromboembolic Complications in Acute Ischemic Stroke with the Low Molecular Weight Heparin Certoparin (PROTECT)
Harenberg J	-	In-vitro Reversal of Anticoagulant Effects of Specific Factor Xa and Thrombin Inhibitors
	-	Follow-Up of Patients with Acute Venous Thromboembolism Treated with Ximelagatran for Prophylaxis of Recurrent Events
	-	Initial Treatment of Patients with Acute Deep-Vein Thrombosis Using 8.000 IU Bid Low-Molecular-Weight Heparin Certoparin – A 24 Months Follow Up
	-	Anticoagulant Effects of Idraparinux Compared to Fondaparinux and Dalteparin
Harenberg J	-	Anticoagulant Effects and Inhibition of Thrombin Generation in Patients on Ximelagatran
Harenberg J	-	Inhibition of Thrombin Generation by Warfarin
Haridas S	-	Functional Analysis of A -13 G/A Dimorphism at the Major Transcription Initiation Site of the Protein Z Gene
Harish VC	-	Isolated Alpha-2 Antiplasmin Deficiency Presenting in a 63 year Old Man
Harish VC	-	Production of a Recombinant Peptide Substrate for the Fluorescence Based Assay of ADAMTS13
	-	Sporadic Occurrence of Warfarin Resistance Secondary to a Val29Leu Mutation In The VKORC1 Protein
Harlan J	-	The Role of Endothelial Cell Apoptosis in Inflammatory and Immune Disease
Harousseau JL	-	Evolution of Antithrombin (AT) and Fibrinogen (Fg) Levels during Induction Chemotherapy with L-asparaginase (Asp) in Adult Patients with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL). Clinical Outcomes and Use of Coagulation Supportive Treatments: The CAPELAL Study
Harper MT	-	Calcineurin and Protein Kinase C Reciprocally Regulate PAR-1 – Dependent Ca²⁺ Release In Human Platelets
Harper AGS	-	A Role for Calpain in Store-Operated Calcium Entry in Human Platelets
Harper J	-	The Use of Temporary IVC Filters for the Prevention of Pulmonary Embolism in High Risk Patients
Harper P	-	Post Treatment Residual Thrombus Is Associated with an Increased Risk of DVT Recurrence, Mortality and a Trend Towards Increased Vascular Death
	-	ZPI Gene Mutations and Myocardial Infarction
Harper PL	-	The D-Dimer Concentration Increases with Age Causing a Marked Effect on the Assay Specificity: Is the D-Dimer Assay Useful As an Exclusion Test in the Elderly?
Harris SL	-	The Effect of Thrombin Activatable Fibrinolysis Inhibitor (TAFI) on Tissue-Type Plasminogen Activator (t-PA) and Urokinase-Type Plasminogen Activator (u-PA) Induced Fibrinolysis in a Plasma Clot Lysis Assay
	-	Thrombin Activatable Fibrinolysis Inhibitor (TAFI) has Different Effects on Fibrinolysis Induced by Tissue-Type Plasminogen Activator (t-PA) and Urokinase-Type Plasminogen Activator (u-PA) in a Whole Blood Thromboelastography Model
Harris AL	-	Analysis of Combination Anti-Angiogenesis Therapy on Markers of Coagulation, Platelet Activation and Angiogenesis in Patients with Advanced Cancer
Harris SB	-	Factor V Inhibitor Acquired after Exposure to High-Purity Topical Bovine Thrombin during Orthopedic Surgery
Harrison N	-	Betaine, a Novel Anticoagulant with Combined Nitric Oxide and Tissue Factor Pathway Release Potential. Implications in the Management of Peripheral Vascular Diseases
Harrison P	-	Aspirin Non-Responsiveness in a Population-Based Study of Acute Vascular Events
Harrison SJ	-	Evaluation of dHPLC in the Genetic Analysis of Fibrinogen Disorders
Harrison P	-	Screening for Aspirin Responsiveness after TIA and Stroke in the Oxford Vascular Study: Comparison of Two Point of Care Platelet Function Tests with Aggregometry
Harrison N	-	Use of Recombinant Activated Factor VII (Novoseven) as Haemostatic Cover for Surgery in Congenital Factor VII Deficiency
Harrison P	-	Plasma Prion Protein (PrP^C) in Patients with Vascular Diseases
Harrison P	-	A Comparison of the Incidence of PFA-100^® Aspirin Non-Responders with 3.2% and 3.8% Citrated Blood (with and without Addition of in Vitro Aspirin)
Harrison JA	-	Treatment of Hemophilia Using Long-Term Venous Access Catheters: A Prospective Multicenter Clinical Trial
Hart GW	-	O-GlcNAc Cycling Is Important for Regulated Platelet Exocytosis
Hartl K	-	Antithrombotic Activity of a Small Molecule Factor XIa Inhibitor in Rats with Limited Effects on Bleeding Time
	-	Development, Characterization and Application of Immunoassays for Mouse, Rat and Rabbit D-Dimer Using the Monoclonal Antibody FK03 in Animal Models of Thrombosis
Hartmut K	-	Alloantigenic Polymorphisms of the b–Terminal Domain Impair the Function of Platelet aIIbb3 Integrin
Hartnett ME	-	Rap1b Is Required for Normal Blood Vessel Formation in Mice
Hartwig JH	-	The Platelet Actin Cytoskeleton Dynamically Reorganizes into Podosomes Upon Cell Adhesion. Identification of a Novel Actin-rich Adhesive Structure in Human Platelets
Hartwig J	-	Platelet Shape and Formation
Hartwig JH	-	The WIP-WASp Complex Modulates Platelet Signaling and Function
Hartwig I	-	A Multicenter Controlled Trial of Anticoagulation Patient Self-Management in Germany Using the Protime System
Harvald T	-	Prolonged Thromboprophylaxis with Dalteparin May Improve Survival in Patients Operated on for Abdominal Cancer
Harvey D	-	Venous Thromboembolism in 68 142 Patients with Colorectal Cancer
Harvey M	-	Molecular Defect of Factor XIII A Subunit in Newfoundland Families with Factor XIII A Subunit Deficiency
Harvey EJ	-	Isolation and Characterization of Human Bone-Derived Endothelial Cells (hBDECs) for the Study of Vascular Bone Disease States
Harvey M	-	Preliminary Results of a Cross-Sectional Study of Mild Hemophilia A in Newfoundland and Labrador, Canada
Harvey D	-	Rates of Venous Thromboembolism (VTE) in Californians with Cancer
Hasebe Y	-	Regulation of Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Gene Expression in Growth-Promoted Hepatocytes and Role of TAFI in Liver Regeneration
Hasegawa H	-	Protective Effect of Endothelial Injury Administrated by Antithrombin Concentrates and Neutrophil Elastase Inhibitor in Endotoxin-Treated Rat
Hasegawa M	-	Active Metabolites of CS-747 (Prasugrel, LY640315) and Clopidogrel Show Similar in vitro P2Y₁₂ Receptor Blockade But Greater in vivo Potency of CS-747
	-	CS-747 (Prasugrel, LY640315), a Novel Antiplatelet Agent, Inhibits Arterial Thrombosis Through Selective Blockade of Platelet P2Y₁₂ Receptors
Hashemi M	-	The Incidence and Penetrance of Common VWF Gene Mutations in a Cohort of Type 1 VWD Patients: Results from the EU Funded MCMDM-1VWD Project
Hashemi M	-	Mutation Profile in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
Hashiguchi T	-	Endocannabinoid Anandamide Induces High Mobility Group Box 1 (HMGB1) Protein Release in Monocytes and Macrophages
	-	Thrombomodulin Binds Lethal Cytokine HMGB1 and Neutralizes Its Pro-inflammatory Activity: Novel Cytoprotective Action of Thrombomodulin
Hassan S	-	The Antithrombotic Activity of Kininogen is Mediated by Inhibitory Effects of Domain 3 on Thrombin-Induced Platelet Activation, In Vivo
Hassell KL	-	Routine Use of Oral Vitamin K for the Reversal of Anticoagulation with Warfarin in Patients Scheduled for Elective Procedures
Hassler M	-	High Incidence of Symptomatic Venous Thromboembolism in Patients with Glioblastoma
Hassouna HI	-	APC Anti-infective Action is Augmented by APC Activation of Protein C
Hasstedt SJ	-	Evidence for Loci Pleotropically Influencing Inter-Related Clotting Factors
	-	Linkage Analysis Reveals No Evidence for Loci Other than the Factor VII Gene Influencing Factor VII Levels
Hatakeyama K	-	Detection of von Willebrand Factor and Tissue Factor in Platelets-Fibrin Rich Coronary Thrombi Causing Acute Myocardial Infarction
	-	Adenovirus-Mediated Transfer of Human Placental Ecto-Nucleoside Triphosphate Diphosphohydrolase to Vascular Smooth Muscle Cells Suppresses Platelet Aggregation in vitro and Arterial Thrombus Formation in vivo
Hathaway WE	-	Clinical Application of the Clot Formation and Lysis (ClofAL) Assay to Physiologic and Pathologic Changes in Factor VIII
Hathcock JJ	-	Role of Phospholipids in the Activation of F.X By Tissue Factor : VIIa
Hathcock J	-	Expression of TFPIb in Normal Human Tissues and Inhibitory Activity on Tissue Factor-Initiated Coagulation Reactions by Recombinant TFPIb from Transfected CHO Cells and Escherichia Coli
Hattori A	-	Protein C Inhibitor Plays a Role as a Potent Regulator of Activated Hepatocyte Growth Factor Activator
Hattori K	-	Factor VIII Mimetic Antibody: (1) Establishment and Characterization of Anti-factor IX/Anti-factor X Bispecific Antibodies
	-	Factor VIII Mimetic Antibody: (2) In Vitro Assessment of Cofactor Activity in Hemophilia A
Hattori T	-	Activated Peripheral Mononuclear Cells Plus Soluble Plasma Tissue Factor (TF) Activate Factors VII and X in Cardiac Surgical Wounds
Hau C	-	Microparticle-associated P-selectin Is a Marker of Platelet Activation in Preeclampsia
Hau RCM	-	Cell-derived Microparticles Contain Caspase 3 in Vitro and in Vivo
	-	Inhibition of Microparticle Release from Endothelial Cells Induces Apoptosis
Haubelt H	-	Factor VIII Activity and Antigen, VWF and ABO-Genotype Are Not Associated with Coronary Heart Disease
	-	Association between Platelet Function Analyzer 100 (PFA-100) Closure Times (CT), Bleeding Time (BT), Platelet Aggregation (PA), Blood Cell Counts, Fibrinogen, Factor VIII (FVIII) and Von Willebrand Factor (VWF)
Haubelt H	-	Monitoring of Heparinization during Extracorporeal Circulation (ECC) with the New Anti-Factor Xa (FXa) Point-of-Care (POC) Clotting Assay Heptest-POC-Hi™
	-	Gene Polymorphisms of Hemostasis And Lipid Metabolism in Apparently Healthy Individuals from Southwest Germany
Haubelt H	-	Reliability of Platelet Function Analyzer 100 (PFA-100™) Closure Times (CT) Induced by Collagen/Epinephrine (CO/EPI) and by Collagen/ADP (CO/ADP)
Hauch O	-	The Relationship Between INR Time-In-Range and Risk of Stroke and Major Bleeds in Chronic Non-Valvular Atrial Fibrillation Warfarin Utilizers
	-	Monitoring International Normalized Ratio (INR) in Patients with Chronic Non-Valvular Atrial Fibrillation: Relationships between INR and Adverse Outcomes?
Hauel N	-	In Vitro Pharmacological Characterization of BIBT 986, A Novel Synthetic Active Site Dual Inhibitor of Thrombin and Factor Xa
	-	Effect of Recombinant Factor VIIa or Activated Prothrombin Complex Concentrate on the Bleeding Time in Anaesthetized Rats during Anticoagulant Treatment with the Direct Thrombin Inhibitor Dabigatran
	-	In vivo Anticoagulant, Antithrombotic and Anti-inflammatory Efficacy of BIBT 986, a Novel Synthetic Active Site Dual Inhibitor of Thrombin and Factor Xa
Hauer A	-	Diabetes Mellitus Does Not Increase Thrombogenicity of the Arterial Vessel Wall in Atherosclerotic LDLr-/- Mice
Haumer M	-	Diagnosis of Central Venous Line-Related Thrombotic Events in the Upper Venous System in Children: Combination of Venography, Venous Ultrasound, and Echocardiography
Hauschner H	-	Further Characterization of the Mutation in Blade 2 of the aIIb b-Propeller That Causes Glanzmann Thrombasthenia in Palestinian Arabs
Hauser HP	-	Selected Human/Porcine Point Substitutions Generated A Human FVIIIa with an Improved Stability
Hauser H-P	-	Mutations in the Protein C Binding Site of Factor VIII Lead to the Resistance of Activated Protein C Cleavage
Havekes LM	-	Clearance of Plasminogen Activator Inhibitor-1 in Low-Density Lipoprotein Receptor-Related Protein Deficient Mice
Havik SR	-	Role of Isoleucine Residues 182 and 183 in Thrombin-Activatable Fibrinolysis Inhibitor
Havik S	-	Thrombin-Activatable Fibrinolysis Inhibitor Deficiency Influences the Inflammatory But Not the Procoagulant/Fibrinolytic Response to Escherichia coli-Induced Abdominal Sepsis in Mice
Hawk S	-	Long-Term Clinical Experience with FEIBA VH in Hemophilia Patients with Inhibitors
Hawkins M	-	Preparation of Reference Materials for the Genetic Diagnosis of Thrombophilia
Hawkins JR	-	Preparation of Reference Materials for the Genetic Diagnosis of Thrombophilia
Hawkins SF	-	A Novel Immunomodulatory Regime for the Eradication of Inhibitors to Factor VIII in a Severe Haemophiliac
Hay C	-	Molecular Pathogenesis of Type 1 von Willebrand Disease (VWD) – A UK National Study
Haya S	-	Molecular Studies in Patients with Type 3 and Type 1 Von Willebrand Disease. New Candidate Mutations
	-	Optimisation of Ristocetin Cofactor Test for Low Activity Samples
	-	von Willebrand Disease Type 2M: Laboratory and Molecular Studies. Results in One Single Centre
Haya S	-	Factor VIII Mutation Type in Severe and Moderate Haemophilia A, and Inhibitor Development in a Congenital Coagulopathies Unit
Haya S	-	Mutational Spectrum of Severe Hemophilia A in A Reference Congenital Coagulopathies Unit: Detection of New Molecular Defects
Hayakawa T	-	Regulation of Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Gene Expression in Growth-Promoted Hepatocytes and Role of TAFI in Liver Regeneration
Hayakawa M	-	A Prospective Comparison of New Japanese Criteria for Disseminated Intravascular Coagulation. New Japanese Criteria vs. ISTH Criteria
Hayashi K	-	Pharmacological Properties of YM-254890, a Specific Ga_q/11 Inhibitor, on Thrombosis and Neointima Formation in Mice
Hayashi T	-	Platelet Thrombus Formation in Blood Vessel-Mimicking Microchannel
	-	Evaluation of Shape Change in Chilled Blood Platelet Using Light Scattering
	-	Analyses of the Interaction of Platelet Collagen Receptor Glycoprotein (GP) VI with Various Types of Collagen
Hayashi T	-	Mechanism of Lipopolysaccharide-induced Decrease of Plasma Protein S: Its Expression in Hepatocytes and Sinusoidal Endothelial Cells Is Mediated by NFkB Activation
Hayashi H	-	Targeted Disruption of Mouse Ortholog of the Human MYH9 Responsible for Macrothrombocytopenia with Different Organ Involvement: Hematological, Nephrological, and Otological Studies of Heterozygous KO Mice
Hayashi M	-	Targeted Disruption of Mouse Ortholog of the Human MYH9 Responsible for Macrothrombocytopenia with Different Organ Involvement: Hematological, Nephrological, and Otological Studies of Heterozygous KO Mice
Hayashi T	-	Protein C Inhibitor Plays a Role as a Potent Regulator of Activated Hepatocyte Growth Factor Activator
Hayashi¹ K	-	Age-Related Effects of Regular Physical Activity on Coagulation Factors in Men
Hayashida H	-	Pulmonary Thromboembolism in Cancer Patients Autopsied in a Japanese General Hospital
Hayes K	-	Over Estimation of Aspirin Resistance: 1 Out of 143 Patients Exhibiting True Aspirin Resistance
Hayes T	-	Use of the D-Dimer for Exclusion of VTE: Difficulties Revealed through the Proficiency Testing Program of the College of American Pathologists (CAP)
Hayes KK	-	The Relation of Dosing to Clopidogrel Responsiveness and the Incidence of High Post-Treatment Platelet Aggregation in Patients Undergoing Coronary Stenting
Hayes PD	-	Metabolism of Arachidonic Acid through 12-LOX in Platelets May Account for Transient Aspirin Resistance Linked to Treatment with Heparin
Hayoz D	-	Characterization of Human Endothelial Progenitor Cells Under Various Flow Conditions
Hayoz D	-	Swiss Atherothrombosis Survey – A Field report on the Occurrence of Symptomatic and Asymptomatic Peripheral Arterial Disease
Hayoz D	-	Egr-1: A Key Mediator of Oscillatory Shear Stress Induction of Tissue Factor Promoter
Hays T	-	A Phase II/III Clinical Study for the Determination of the Efficacy and Safety of Protein C Concentrate in Subjects with Severe Congenital Protein C Deficiency – Interim Study Analysis
	-	Survival and Thromboembolic Outcomes of Septic Jugular Vein Thrombosis (Lemierre's and Lemierre-Like Syndromes) in Children
Hayward CPM	-	Identification of the Multimerin 1 Binding Region within the C1 Domain of Factor V
Hazenberg BPC	-	Binding of Amyloid to the Fibronectin Type I Domain of tPA And Factor XII Induces Activation of the Fibrinolytic System and the Contact System
He S	-	Low Dose-beneficial Effects of Acetylsalicylic Acid (ASA) Modify Fibrinogen Clotting Property in a Purified System Leading to Increase of the Fibrin Gel Porosity
He SL	-	Pentoxifylline Protects Rats from Endotoxin-Induced Disseminated Intravasvular Coagulation by Inhibiting the Elevations of TNFa and Tissue Factor
He R	-	Pentoxifylline Protects Rats from Endotoxin-Induced Disseminated Intravasvular Coagulation by Inhibiting the Elevations of TNFa and Tissue Factor
He XF	-	Mechanism for the Inhibitory Effect of Tetramethylpyrazine on the Expression of Tissue Factor Induced by Tumor Necrosis Factor in ECV304 Cells
He SL	-	Mechanism for the Inhibitory Effect of Tetramethylpyrazine on the Expression of Tissue Factor Induced by Tumor Necrosis Factor in ECV304 Cells
He XF	-	Effects of Angiotensin-(1–7) on the Expression of Tissue Factor Induced by Angiotensin II and its Mechanisms in Vascular Endothelial Cells
He SL	-	Effects of Angiotensin-(1–7) on the Expression of Tissue Factor Induced by Angiotensin II and its Mechanisms in Vascular Endothelial Cells
He S	-	Recombinant Tissue Factor (rTF) and Tissue-Plasminogen Activator (t-PA) Used in a Global Assay to Determine Overall Haemostasis Potential (OHP) in Plasma
He XF	-	Changes of Tissue Factor Pathway in Patients with Hypertension and Coronary Heart Disease
He SL	-	Changes of Tissue Factor Pathway in Patients with Hypertension and Coronary Heart Disease
He S	-	Study on Platelet-Associated Tissue Factor and Its Significance in Thrombotic Diseases
He J	-	Platelet Antibody Analysis in Patients with Platelet Transfusion Refractoriness
He XF	-	Effects of Siwu Tang on the Tissue Factor Expression of Astrocytes from Neonatal Rat
He SL	-	Effects of Siwu Tang on the Tissue Factor Expression of Astrocytes from Neonatal Rat
He XF	-	Influence of Tetramethylpyrazine on the Expression of Tissue Factor Induced by IL-6 in Vascular Endothelial Cells
He SL	-	Influence of Tetramethylpyrazine on the Expression of Tissue Factor Induced by IL-6 in Vascular Endothelial Cells
He XF	-	Influence of Cinnamic Acid on the Expression of Tissue Factor Induced by Tumor Necrosis Factor a and Its Mechanism in Vascular Endothelial Cells
He SL	-	Influence of Cinnamic Acid on the Expression of Tissue Factor Induced by Tumor Necrosis Factor a and Its Mechanism in Vascular Endothelial Cells
He XF	-	Tetramethylpyrazine Inhibits Apoptotic Cell Death of Cultured Endothelial Cells Induced by Tumor Necrosis Factor-alpha
He SL	-	Tetramethylpyrazine Inhibits Apoptotic Cell Death of Cultured Endothelial Cells Induced by Tumor Necrosis Factor-alpha
He S	-	The Effect of Platelets on Fibrin Gel Structure Formed in the Presence of Recombinant Factor VIIa in Haemophilia Plasma and in Plasma From a Patient with Glanzmann Thrombasthenia
Healey JF	-	Characterization of Anti-Human and Anti-Porcine Factor VIII Monoclonal Antibodies Produced by Hemophilia A Mice
Hebbel RP	-	Therapeutic Inhibition of Endothelial Tissue Factor Expression by Nitric Oxide and Other Agents in Sickle Transgenic Mice
Hebbel RP	-	NF-kB Activation Mediates Deep Vein Thrombosis: Inhibition by the NF-kB Inhibitor Andrographolide and Its Derivatives
Heck AJR	-	Activation of the Fibrinolytic System by Amyloid Cross-b Structure Results In reply to: Cell Detachment AND Processing of Neuroendocrine Factors
Hedger S	-	An Audit on D-dimer Use in the Assessment of Patients with Suspected Acute Pulmonary Embolism
Hedner U	-	The Effect of Platelets on Fibrin Gel Structure Formed in the Presence of Recombinant Factor VIIa in Haemophilia Plasma and in Plasma From a Patient with Glanzmann Thrombasthenia
	-	Hemophilia B Mice Have Delayed Wound Healing
Heeb MJ	-	Protein S Multimers and Monomers Each have Direct Anticoagulant Activity and Exist in Plasma
Heeb MJ	-	Phospholipids (PL) Induce a Conformational Change Required for Protein Z-Dependent Protease Inhibitor (ZPI) Inhibition of Factor Xa But Not Factor IXa
Heemskerk JWM	-	Slower Translocation of Platelets at High Shear Rate without Increased Calcium Signals on Type 2B Recombinant Von Willebrand Factor
	-	Crosstalk Between Integrins a2b1 and aIIbb3 during Platelet Activation
	-	Platelet ADP Receptor Function Rapidly Deteriorates in Additive Solutions
	-	Crucial Role of Glycoprotein VI in Thrombus Formation and Coagulation during Venous and Arterial Thrombosis
	-	P2Y₁₂ Receptor Stimulation Prolongs Thrombin-Induced Calcium Responses and Procoagulant Activity Via Novel Signaling Pathways; Variable Effect of Clopidogrel Treatment
	-	Plasma Ecto-NTPDase Prevents Platelet P2X₁ and P2Y₁₂ Receptor Desensitization During Storage
	-	Integrins Mediate Shedding of Procoagulant Microparticles at Minimal Platelet Activation
	-	Disclosure of Microdomain Structure and Function in Arterial Thrombi of Heterogeneous Composition
	-	Roles of Platelet ADP and Gas6 Receptors in Thrombus Stability
Heemskerk JW	-	Inhibition of Collagen-Induced Thrombus Formation by Insulin Is Absent in Diabetes Mellitus Type 2
Heemskerk JWM	-	Inhibition of Protein Kinase C Results in an Altered Thrombus Phenotype with Suppressed Platelet Aggregation and Increased Platelet Procoagulant Activity
	-	Role of Integrin a2b1 in Thrombus Stabilization and Embolization
	-	NF279 Inhibits the Contribution of P2X₁ to Arteriolar Thrombosis Via Partial Agonism
	-	Tissue Factor- and Collagen Triggered Thrombosis in vivo Relies on Platelet-Dependent Thrombin Generation in Both Arterioles and Venules
Heeremans J	-	Platelet ADP Receptor Function Rapidly Deteriorates in Additive Solutions
Heeringa P	-	A Hypercoagulable State in Myeloperoxidase Deficient Mice
Hegadorn C	-	Understanding the Genotype/Phenotype Link in Type 1 von Willebrand Disease (VWD): Results from The Canadian Type 1 VWD Study
	-	The Mutational Spectrum of Type 1 Von Willebrand Disease (VWD): Results from the Canadian Type 1 VWD Study
Heger A	-	Removal of PrP^Sc in the Manufacturing Process of OCTAPLAS and UNIPLAS
Heguilen R	-	Hyperhomocysteinemia, Anticardiolipin Antibodies, and Risk for Vascular Access Thrombosis in Hemodialysis Patients
Heiden van der Y	-	Coagulation Disorders in Severe leptospirosis in Indonesia
Heifetz S	-	Re-evaluation of Point-of-Care (POC) Monitors for Routine Oral Anticoagulation Clinic Use
Heijnen HFG	-	Adhesive Surface Determines Raft Composition in Platelets Adhering Under Flow
Heikki Vanannan	-	Role of Phospholipids in the Activation of F.X By Tissue Factor : VIIa
Heil SG	-	Evidence for a Critical Role of the Modifying Subunit of Glutamatecysteine Ligase in Homocysteine Pathophysiology
Heilmann L	-	Prevention of Venous Thromboembolism with Low-Molecular-Weight Heparin in Patients with Metastatic Breast or Lung Cancer – Results of the TOPIC Studies
Heim M	-	Comparative Investigation of Prothrombin Complex Concentrates: Differences in Levels of Markers Indicating Activation of Coagulation
Hein L	-	Reduced Thrombus Stability in Mice Lacking the a_2A-Adrenergic Receptor
Heine RJ	-	The Phospholipid Composition of Cell-derived Microparticles Changes in the Postprandial State
Heine GH	-	Monocyte Subsets in Early Atherosclerosis – Lessons Learnt at Home
Heine RJ	-	In Type 2 Diabetes, P-Selectin- But Not CD63 -Exposing Microparticles Are Elevated in the Postprandial State
Heinz S	-	Both, COP I and COP II Coatomers Are Involved in the Anterograde ER to Golgi Transport of B-domain Deleted FVIII
Heistinger M	-	Mutations in the VKORC1 Gene Cause Warfarin Resistance, Warfarin Sensitivity and Combined Deficiency of Vitamin K Dependent Coagulation Factors
Heit JA	-	Quality of Life (QoL) Evaluation in Women with Menorrhagia and Inherited Bleeding Disorders
Heit JA	-	Risk Factors for Venous Thromboembolism (VTE) among Patients Hospitalized for Acute Medical Illness: A Population-Based Case-Control Study
	-	Venous Thromboembolism: Disease Burden, Outcomes and Risk Factors
Heit JA	-	Congenital Platelet ADP Receptor (P2Y₁₂) Deficiency: A Case Report
Heit JA	-	Risk Factors for Venous Thromboembolism (VTE) Among Patients Hospitalized for Major Surgery: A Population-Based Case-Control Study
Heit JA	-	Evaluation of Glass versus Plastic Blood Collection Tubes Used in Coagulation Testing
	-	Sensitivity of Dilute Russell's Viper Venom Time (DRVVT) to Coagulation Factor Deficiency: Effect on Testing for Lupus Anticoagulant
Hekim N	-	The Effects of Clopidogrel and Nadroparine on Elevated Thrombolytic Risk and Apoptotic Process in Hypercholesterolemia
Hekmatian N	-	Evaluation of Pro-angiogenic and Pro-Coagulant Activity of Irradiated, Non Irradiated and Filtered Stored Blood Used in Transfusion Practice
Helgeson E	-	A Multi-centre Assessment of the Chromogenic Method for Factor VIII:C Estimation in Plasma-derived and Recombinant Concentrates
Heller C	-	Risk of Recurrent Venous Thromboembolism in Children with Cerebral Venous Thrombosis – A Prospective Follow-Up Cohort Study
Helley D	-	Low Molecular Weight Fucoidan Is More Effective Than Low Molecular Weight Heparin in Preventing Arterial Thrombosis in a Rabbit Model
Hellstern P	-	Gene Polymorphisms of Hemostasis And Lipid Metabolism in Apparently Healthy Individuals from Southwest Germany
	-	Monitoring of Heparinization during Extracorporeal Circulation (ECC) with the New Anti-Factor Xa (FXa) Point-of-Care (POC) Clotting Assay Heptest-POC-Hi™
Hellstern P	-	Reliability of Platelet Function Analyzer 100 (PFA-100™) Closure Times (CT) Induced by Collagen/Epinephrine (CO/EPI) and by Collagen/ADP (CO/ADP)
Hellstern P	-	Factor VIII Activity and Antigen, VWF and ABO-Genotype Are Not Associated with Coronary Heart Disease
Hellstern P	-	Association between Platelet Function Analyzer 100 (PFA-100) Closure Times (CT), Bleeding Time (BT), Platelet Aggregation (PA), Blood Cell Counts, Fibrinogen, Factor VIII (FVIII) and Von Willebrand Factor (VWF)
Helm CA	-	The Molecular Structure of the Antigen in Heparin-induced Thrombocytopenia
Hemberger M	-	Inhibition of Platelet Activation in Diabetic Rats by Chronic Treatment with the Guanylyl Cyclase Activator HMR1766
Hemker HC	-	The Thrombogram in Twins, Influence of Oral Contraceptive and Intercurrent Infection
	-	The Effect of SC Injection of Heparins of Different Molecular Weight on Thrombin Generation – Consequences for the Question of Monitoring Heparin Treatment
	-	The Relation Between in vitro Thrombin Generation and Signs of in vivo Thrombin Generation; Influence of Pro- and Anti-coagulant Plasma Factors
	-	Rofecoxib (Vioxx) Increases Thrombin Generation in Platelet Rich Plasma
	-	The Use of Calibrated Automated Thrombin Generation to Detect Alterations of the Clotting System Brought About by Hormone Administration in Pre- and Postmenopausal Women
	-	Lupus Anticoagulants IgG with or without Anti-b₂-Glycoprotein I Induced Acquired Activated Protein C Resistance Evidenced by Calibrated Automated Thrombography
Hempel M	-	Anti-Prothrombin Antibodies in Women with Vascular Pregnancy Complications and in Patients with Thrombosis and Suspected Antiphospholipid Syndrome (APS)
Henckel T	-	Measuring Thrombin Generation as a General Parameter in Relation to Single Coagulation Tests
	-	Measuring Thrombin Generation as Marker of Hypercoagulation in Patients with Lung Cancer
	-	Analytical Evaluation of a Fully Automated Chromogenic Assay for the Determination of Endogenous Thrombin Potential (ETP)
	-	Thrombin Generation as Parameter to Monitor Patients with Thrombophilia and Pregnancy
Henderson RB	-	Evaluation of the Roles of Rac1 and Rac2 in Lamellipodia and Aggregate Formation on Collagen Under Flow
Hendler MF	-	Hyperhomocysteinemia, Anticardiolipin Antibodies, and Risk for Vascular Access Thrombosis in Hemodialysis Patients
Hendriks D	-	Patients with Mucocutaneous Bleeding and Hereditary Disorders of Primary Haemostasis Have Higher Plasma proCPU Levels But a Similar Distribution of the 325 Thr/Ile Polymorphism Compared to Age and Sex Matched Healthy Controls
	-	A Novel Coupled Enzymatic Assay for the Fast Kinetic Characterization of Synthetic and Physiological CPU (TAFIa) Substrates
	-	Plasma proCPU (TAFI) Concentrations and Clot Lysis Time Are Not Different in a Chilean Population of Young Healthy Individuals Subgrouped According to the Naturally Occurring 325 Thr/Ile Polymorphism
Hendrikson SB	-	Thrombophilia-Associated Fetal Loss: Epistasis of Fetal and Maternal Factors
	-	Cell Death Induced by Fibrin-Degradation Products
Hendry M	-	Preliminary Results of a Cross-Sectional Study of Mild Hemophilia A in Newfoundland and Labrador, Canada
	-	Molecular Defect of Factor XIII A Subunit in Newfoundland Families with Factor XIII A Subunit Deficiency
Henke P	-	Oral PAI-1 Inhibitor Decreases Thrombosis Without Anticoagulation in a Rat Stenosis Model of Venous Thrombosis
	-	Prophylaxis using a Novel Oral Small Molecule Inhibitor to the P-selectin Receptor Promotes Thrombus Resolution in a Baboon Model of Venous Thrombosis
Hennan JK	-	Prevention of Canine Coronary Artery Thrombosis by the von Willebrand Factor Antagonist, GPG290
Hennig J	-	Superparamagnetic Iron Oxide Uptake as Imaged By Magnetic Resonance Is Mediated by the Integrin Receptor MAC-1 (CD11b/CD18) – Possible Implications on Imaging of Atherosclerotic Plaques
Henning S	-	Factor VII Activating Protease (FSAP) Inhibits Angiogenesis in vivo
Henny ChP	-	Incidence of Deep Vein Thrombosis after Knee Arthroscopy without Thromboprophylaxis
	-	Sustained Factor VIII and vWF Elevation after Total Hip Arthroplasty
Henriet C	-	WILFACTIN: Efficacy and Safety Evaluation of WILFACTIN (a Triple Secured Von Willebrand Factor Product with a Low Factor VIII Content) in Women with Severe Von Willebrand Disease during Gynaecological/Obstetrical Events
Henriksson CE	-	Lipopolysaccharide-induced Monocyte Procoagulant Activity – Discrepancy Between Tissue Factor Activity and Tissue Factor Expression May Reside in Increased Phosphatidylserine Exposure Due to Cell Death
Henschen A	-	Delayed FPA Release from Homophenotypic Aa 16 H (Fibrinogen Kingsport): Major b Fibrin Epitope Role in Clotting Times and Branching
Henschler R	-	Chemically Distinct Anticoagulants Exert Differential Effects on Experimental Melanoma Metastasis
Hepner M	-	Low Molecular Weight Heparin (LMWH) Therapy in Neonates and Children with Venous Thromboembolism (VTE)
	-	Platelet Aggregation and ATP Release Values in Children and Adults
Heptinstall S	-	Derivatives of Coenzyme A Inhibit Platelet Aggregation via Effects at P2Y₁ and P2Y₁₂ Receptors
Heptinstall S	-	Raised Blood Leukocyte Counts Markedly Alter Platelet Aggregation Extent induced by ADP and ATP via CD39
	-	Dietary Flavanols – Effects on Platelets and Leukocytes
	-	Involvement of P2Y₁and P2Y₁₂Receptors in Platelet Responses to Adenosine Diphosphate and Thrombin Receptor Activating Peptide
	-	Effects of Granulocyte-Colony Stimulating Factor on Platelet and Leukocyte Function in Whole Blood in vitro
	-	Platelet Aggregation, Microparticle Formation and Platelet-Leukocyte Conjugate Formation Induced by Combinations of 5-HT and Epinephrine Are Inhibited by Sarpogrelate and BP-984
	-	Contributions of Blood Cells to Adenine Nucleotide Metabolism
Heras I	-	Acquired Antithrombin Deficiency in Acute Lymphoblastic Leukaemia (ALL) Induced by L-Asparaginase (ASNase): A Conformational Mechanism Modulated by Dexamethasone
Hérault J-P	-	Fgf-Receptor Signalling is Involved in Differentiation and Recruitment of Bone Marrow Progenitor Cells into Endothelial Progenitor Cells
Herbel P	-	INR Results of the CoaguChek® PT Test Compare Well with INR Results of International Reference Thromboplastins
Herbert J-M	-	Mice Lacking Gas6 are Protected from Graft-Versus-Host Disease in the Liver Due to a Reduced Activation of the Endothelium
Herbert J-M	-	Fgf-Receptor Signalling is Involved in Differentiation and Recruitment of Bone Marrow Progenitor Cells into Endothelial Progenitor Cells
Herbert J-M	-	VEGF-R2 and Neuropilin-1 Are Involved in VEGF-A-Induced Differenciation of Human Bone Marrow Progenitor Cells
Herchenhan E	-	Safety and Efficacy of Low-Molecular-Weight Heparin (Dalteparin) in Pregnant Women at Increased Risk of Venous Thromboembolism: A Prospective Stratified Multicentre Trial
Heresi GA	-	Endothelial Microparticle Binding to Neutrophils Is an Important Determinant of Neutrophil Activation In Vivo in Different Clinical Conditions
Hergenroeder GW	-	Heparin Antibodies in Intensive Care Unit Patients (The HAICU Study)
Hermans C	-	Exposure to Diesel Nanoparticles Does Not Induce Blood Hypercoagulability in an at-Risk Population
	-	Angiographic Documentation of the Efficacy of Recombinant Activated Factor VII (Novo Seven) to Control Diffuse Bleeding in Major Trauma
Hermsen JT	-	Safe Exclusion of Deep Vein Thrombosis (DVT) by a Normal Rapid ELISA D-Dimeer (<500 Ng/Ml) and by the Combination of a Negative Compression Ultrasonography and a D-Dimer of <1000 Ng/Ml in 1330 Consecutive Outpatients with Suspected DVT in the Primary Care Setting
Hermsen CC	-	Malaria Infection Induced Thrombocytopenia Is not Related to Systemic Platelet Activation
Hermus AR	-	A Genome-Wide Linkage Scan for Homocysteine Levels Identifies Three Regions of Interest
	-	Low Methionine Concentration as a Risk Factor for Recurrent Venous Thrombosis
Hernandez F	-	Surgery in Haemophilic Patients with Inhibitor
Hernandez J	-	Favorable Outcome in the Pregnancy behind Treatment with Heparin in Women with Mutation of Methylenetetrahydrofolate Reductase (MTHFR) Gene and Fetal Loss Previous
Hernandez F	-	Efficacy, Safety and Pharmacokinetic Properties of ADVATE rAHF-PFM in Previously Treated Patients (PTPs) Less Than 6 years of Age
Hernandez I	-	Cell Death Induced by Fibrin-Degradation Products
Hernández F	-	Polipectomia in a Patient with a Moderate Congenital Deficiency of Factor V
Hernández-Espinosa D	-	Non-enzymatic Glycation of Antithrombin: Implications in Diabetes Mellitus
Hernanz P	-	Clinical Course and Management of 7 Patients with Congenital Factor XIII Deficiency. Experience of a Single Institution
Hernández-Espinosa D	-	Conformational and Functional Changes in Antithrombin by Oxidation
	-	Acquired Antithrombin Deficiency in Acute Lymphoblastic Leukaemia (ALL) Induced by L-Asparaginase (ASNase): A Conformational Mechanism Modulated by Dexamethasone
	-	Inflammation and Coagulation in Two Models of Endotoxemia in Resistant and Sensitive Mice: Low Relevance of Activation of Coagulation in the Outcome
	-	Clearance of Latent and Polymeric Antithrombin. Are These Conformational Variants Prothrombotic?
Herrera M	-	Clinical Course and Management of 7 Patients with Congenital Factor XIII Deficiency. Experience of a Single Institution
Herrmann FH	-	Factor X Deficiency: Clinical Manifestation of 102 Subjects with Mutations in Factor 10 Gene
Herrmann FH	-	Gynaecological Problems in Severe Congenital Factor VII Deficiency
Hersemeyer K	-	The Factor VII Activating Protease (FSAP) Is an Inhibitor of Neointimal Lesion Formation. Comparison with the Marburg I SNP (G511E) of FSAP
	-	The Junctional Adhesion Molecule-C Promotes Neutrophils Transendothelial Migration in vitro and in vivo
	-	Urokinase Receptor (uPAR)(CD87) – Clustering in Detergent Insoluble Adhesion Patches (DIAP) Leads to Cell Adhesion on a Vitronectin Matrix
Hertfelder H-J	-	Usefulness of a Particle Gel Immunoassay (PaGIA) for Rapid Diagnosis of Heparin-Induced Thrombocytopenia
Hervig T	-	The INTERCEPT Blood System for Plasma: Process Validation Studies of Coagulation Factor Activity and Yield in Three European Blood Centers
Herzog W	-	Hypercoagulability Measured By TEG Strongly Predicts Recurrent Ischemic Stents Post Coronary Stenting
Herzog S	-	Hyperglycemia Induces Loss of the Protective Endothelial Thrombomodulin Protein C System
	-	A Unique Fusion Protein Combines Clot Targeting, Platelet Blockade and Direct Factor Xa Inhibition in One Molecule
Herzog A	-	Quantification of ADAMTS13 Antigen Levels in Healthy Donors and Patients with Thrombotic Microangiopathies by a Newly Developed Sandwich ELISA
Hess Z	-	Clinical and Laboratory Risk Factors in a Group of Patients with Venous Thromboembolism
Hess O	-	Redox-Regulated Coupling of ADP Receptor Signaling and Integrin Function in Platelets
Hesse B	-	New Scintigraphic Method for Imaging of Gastro-intestinal Bleeding: Preliminary Results from Ex Vivo Studies in Rabbits
Hetherington R	-	A Negative Venous Duplex Ultrasound Scan Alone Excludes Deep Venous Thrombosis in Clinical Practice
Hetland Ø	-	Plasma Concentrations of Soluble Fibrin, D-dimer, Myeloperoxidase and Pregnancy Associated Plasma Protein A before and after Treatment with PCI or Thrombolysis for Acute Myocardial Infarction
Hevelow ME	-	The Variability of Platelet Function Testing
Hevessy Z	-	Comparative Evaluation of FXIIIA and P-selectin Expression on the Surface of Thrombin-activated Platelets and Microparticles
Heward J	-	Hypertonic Stress Alters the Yield and Type of Microparticles Produced by Haemopoietic Cells
Hewett J	-	Platelets Provide Factor IX (FIX) and Factor X (FX) to Support Dilute Tissue-factor Dependent Coagulation
Hewitt J	-	Molecular Characterization of a 4.4 Mbp Deletion of the X Chromosome in a Male with Hemophilia B
Hewson J	-	Functional Analysis of Obligate Heterozygous Defects in Platelet Glycoprotein (GP) Ib-V-IX in Velo-Cardio-Facial Syndrome (VCFS) Patients
Heyland D	-	Validation of Overt Disseminated Intravascular Coagulation (DIC) Scoring Algorithm Use in Critically Ill Patients: Correlation with Inflammatory Markers and APACHE and SOFA Scores
Heysen J	-	A High Prevalence of Ankle Arthropathy in Mild and Moderate Haemophilia A in South Australia and a Threshold Effect of FVIII Level on Its Occurrence
Hickey MJ	-	Anti-Neutrophil Cytoplasmic Antibodies (ANCAs) Promote Leukocyte Adhesion in the Glomerular Microvasculature
Hicks G	-	Paradoxical Example of Warfarin Exerting Anti-Thrombotic Effect without Significantly Altering Template Bleeding Times in Rabbits
Hideo W	-	High Mobility Group Box Protein Is Increased in the Plasma and May Have a Role in Development of Organ Failure in DIC
Hideo W	-	Diagnosis of Deep Vein Thrombosis by Soluble Fibrin or D-dimer
Hiebert L	-	Heparins Are Transported Across Rat Gastric Mucosa. Studies in a Verticle Diffusion Chamber
Hiebert LM	-	Oral But Not Subcutaneous Heparin Prevents Heparanase mRNA Upregulation in Liver and Kidney of High Glucose Treated Rats
Hiebinger C	-	Immunate S/D – Results of a Phase III, Prospective, Multicenter Study to Evaluate the Pharmacokinetics, Immunogenicity, Safety, and Efficacy of Immunate Solvent Detergent in Previously Treated Patients with Severe or Moderately Severe Hemophilia A
Higaki N	-	Pulmonary Thromboembolism in Cancer Patients Autopsied in a Japanese General Hospital
Higashihara M	-	Molecular Cloning of 20-kDa Myosin Light Chain Isoforms in Human Platelets
Higgins J	-	Fibronectin-Binding Protein (FnBP) Mediates Staphylococcus Aureus-Induced Platelet Aggregation
Higgins LA	-	Proteomic Analysis of Platelets and Platelet-Derived Microparticles by iTRAQ Labeling and Mass Spectrometry
Higgins CF	-	Reduced Expression of ABCA1 and A Novel Missense Mutation That Results in Altered Protein Trafficking Underlie Scott Syndrome
High KA	-	Characterization and Gene Silencing of a Novel Gla-Containing Protein
High Katherine	-	Gene Transfer for Hemophilia: can Therapeutic Efficacy in Large Animals be Safely Translated to Patients?
High KA	-	Hemostatic Effects of Long-Term Expression of Activated Murine FVII in Normal and Hemophilic Mice
Higuchi T	-	Verotoxin-1 Activation of the c-Yes in Human Monocytes/THP-1 Monocytic Cells Induces Tissue Factor Expression Through Activations of IKKbeta/NF-kappaB/Rel and ERK/Egr-1 Pathways
Höijer P	-	Elevated Coagulation Factor VIII and Free Flap Failure after Late Breast Reconstruction with a TRAM Flap
Hijkata-Okunomiya PA	-	Structure-activity Relationship of Arginine Derivatives and Staphylothrombin Inhibitory Activity
Hilbert L	-	In vitro Expression of Ten Missense Mutations in the VWF C-Terminal Domain Identified in Patients Diagnosed with Type 1 VWD: Results from the MCMDM-1VWD Study
	-	A Reduced VWF to FVIII Binding Capacity is not Uncommon in Patients With Type 1 Von Willebrand Disease: Results From the MCMDM-1VWD Study
	-	Two Novel Type 1 Von Willebrand Disease Causing Mutations (G160W and N166I) in the Von Willebrand Factor Propeptide, Identified in the European Study MCMDM-1VWD, Are Responsible for Multimerization And Secretion Defects
	-	Cysteine Mutations in the von Willebrand Factor D3 Domain Correlate with Multimerization Defects in Patients Previously Diagnosed with von Willebrand Disease Type 1 in Patients Entered in the European Multicentre Study MCMDM-1VWD
	-	Bilateral Ankle Prosthesis in a Severe Von Willebrand Disease Patient under Substitutive Wilfactin Treatment
Hilbrands LB	-	Predictive Value of the Platelet Function Analyser (PFA-100^®) for Post Biopsy Bleedings in Patients Undergoing Renal Biopsy
Hilgartner M	-	Evaluation of FEIBAVH in Patients with an Inhibitor and Hemophilic Arthropathy
Hill F	-	A Reduced VWF to FVIII Binding Capacity is not Uncommon in Patients With Type 1 Von Willebrand Disease: Results From the MCMDM-1VWD Study
Hill FGH	-	Pseudo von Willebrand Disease: 2B or not 2B? Cryoprecipitate Induced Platelet Aggregation Solves Hamlet's Dilemma
Hill F	-	Two Novel Type 1 Von Willebrand Disease Causing Mutations (G160W and N166I) in the Von Willebrand Factor Propeptide, Identified in the European Study MCMDM-1VWD, Are Responsible for Multimerization And Secretion Defects
	-	Association of FVIII/Von Willebrand Factor Measurements and PFA-100® with Bleeding Score in Type 1 Von Willebrand Disease (VWD) Families. The MCMDM-1 Study
	-	Multimer Pattern in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
	-	In vitro Expression of Ten Missense Mutations in the VWF C-Terminal Domain Identified in Patients Diagnosed with Type 1 VWD: Results from the MCMDM-1VWD Study
Hill M	-	Evaluation of dHPLC in the Genetic Analysis of Fibrinogen Disorders
Hill FGH	-	41 Novel Factor VIII Mutations Identified in Haemophilia A Families from the UK Midlands Region
Hill F	-	Molecular Pathogenesis of Type 1 von Willebrand Disease (VWD) – A UK National Study
	-	Cysteine Mutations in the von Willebrand Factor D3 Domain Correlate with Multimerization Defects in Patients Previously Diagnosed with von Willebrand Disease Type 1 in Patients Entered in the European Multicentre Study MCMDM-1VWD
	-	Linkage Analysis of von Willebrand Disease Type 1 Phenotype, von Willebrand Factor Levels and Bleeding Symptoms with Von Willebrand Factor Gene Locus in the European Multicenter MCMDM-1VWD Study
	-	Mutation Profile in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
	-	Responsiveness to Desmopressin: Influence of Genotype in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD
Hill FGH	-	Early FVIII Exposure and Subsequent Inhibitor Development in Children with Severe Haemophilia A
Hill F	-	Abnormal Multimeric Pattern Is Not Associated with Increased Bleeding Symptoms in Index Cases of Families with Type 1 VWD. Results from the EU MCMDM-1 VWD Study
	-	Assay of the von Willebrand Factor Propeptide (VWFpp) to Identify Type 1 von Willebrand Disease (VWD) Patients with a Decreased von Willebrand Factor (VWF) Survival Phenotype
	-	The Factor VIII/von Willebrand Factor Antigen (FVIII/VWF : Ag) Ratio in Determining VWF Defects in Patients with von Willebrand Disease Type 1: Results from the European Multicenter MCMDM-1VWD Study
Hill FGH	-	Seven Novel Candidate Mutations in Exon 27 and 28 of von Willebrand Gene in Patients with Type 1, Type 2 M and Unclassified von Willebrand Disease
Hill F	-	The Incidence and Penetrance of Common VWF Gene Mutations in a Cohort of Type 1 VWD Patients: Results from the EU Funded MCMDM-1VWD Project
	-	Collagen Binding (VWF : CB) Is Less Sensitive Than Ristocetin Cofactor Activity (VWF : RCo) in Suggesting Von Willebrand Factor (VWF) Molecular Defects in Patients with Von Willebrand Disease Type 1: Results From the European Multicenter MCMDM-1VWD Study
	-	Analysis of Bleeding Score in Type 1 VWD Families in the MCMDM-1 Study
Hillarp A	-	Large Deletions Explain Protein S Deficiency in Many Cases Where Previous Mutation Detection Has Failed
	-	The Prevalence of Low von Willebrand Factor Activity and von Willebrand Disease Among Young Women with Bleeding Symptoms
	-	Co-segregation of the PROS1 Locus and Protein S Deficiency in Families having no Detectable Mutations in PROS1
Hillege HL	-	Risk of Thromboembolic Events and Major Bleeding in Patients Treated with Vitamin K Antagonists after Heart Valve Replacement (HVR); Individual Time within Target Range (ITTR) an Accurate Predictor
	-	Clinical Implications of Individual Time Within Target Range (ITTR) in Patients with Atrial Fibrillation (AF) treated with Vitamin K Antagonists
	-	Individual Time within Target Range (ITTR), an Accurate Predictor of Clinical Outcome in Patients with Acute Myocardial Infarction (AMI) Treated with Vitamin K Antagonists
Hilliard P	-	Results from the Canadian Hemophilia Dose Escalation Prophylaxis Trial: An Update
Hillman A	-	A Novel Case of Familial Thrombocytopenia with Evidence for a Critical Role of Proteins Involved in Ca²⁺ Signaling in Megakaryocytopoiesis
Hillmann AG	-	Accurate RNA Transcript Profiling of Platelets from Clinically Relevant, Small Blood Volumes
Hillmayer K	-	Expression and Characterization of Rat TAFI
Hillyer C	-	Therapeutic Plasma Exchange (TPE) for Thrombotic Thrombocytopenic Purpura (TTP) Using Plasma Prepared With Photochemical Treatment: Clinical Responses, vWF CP Levels and vWF-CP Inhibitor Levels
Hilpert M	-	Podoplanin-Induced Platelet Aggregation is Responsible For Separation of Blood and Sprouting Lymphatic Vessels during Embryonic Development
Hilton A	-	Molecular Dissection of Platelet Production Via Random Mutagenesis
Hilton DJ	-	Molecular Dissection of Platelet Production Via Random Mutagenesis
Hiltunen L	-	Thrombophilia: A New Potential Risk Factor for Cervix Insufficiency
Himbert D	-	Enhanced Shear-Induced Platelet Aggregation in Patients Who Experienced Subacute Stent Thrombosis: A Case-Control Study
Hinder M	-	Inhibition of thrombin generation by Otamixaban (XRP0673), a direct and selective factor Xa inhibitor
	-	Otamixaban, a Direct Factor Xa Inhibitor, More Potently Inhibits Experimental Coronary Thrombosis than Bivalirudin, a Direct Thrombin Inhibitor
Hirai M	-	The Japanese Vein Study: The 2^nd Survey of Deep Vein Thrombosis
Hirano K	-	Functional Analysis o Two Recombinant Missense Mutant Factor XI, F221S ad C212R
Hirashima K	-	Targeted Disruption of Mouse Ortholog of the Human MYH9 Responsible for Macrothrombocytopenia with Different Organ Involvement: Hematological, Nephrological, and Otological Studies of Heterozygous KO Mice
Hirayama F	-	Platelet Thrombus Formation in Blood Vessel-Mimicking Microchannel
	-	Evaluation of Shape Change in Chilled Blood Platelet Using Light Scattering
	-	Effects of Recombinant Antithrombin Expressed in Chinese Hamster Ovary Cells on Endotoxin- or Thromboplastin-Induced DIC in Rats and Concanavalin A-Induced Liver Injury in Mice
Hirmerová J	-	Clinical and Laboratory Risk Factors in a Group of Patients with Venous Thromboembolism
Hirnle T	-	Thrombin Activatable Fibrinolysis Inhibitor (TAFI) in Stable Angina Pectoris Patients Undergoing Coronary Artery Bypass Grafting (CABG)
Hirohata K	-	Prevention of Postoperative Pulmonary Embolism in the Japanese Academic Medical Center
Hirosawa S	-	Endoplasmic Reticulum-Associated Degradation of Naturally Occurring Protein C and Plasmin Inhibitor Mutants
Hirose M	-	Purification and Characterization of Recombinant Antithrombin Expressed in Chinese Hamster Ovary Cells
Hirose M	-	Effects of Recombinant Antithrombin Expressed in Chinese Hamster Ovary Cells on Endotoxin- or Thromboplastin-Induced DIC in Rats and Concanavalin A-Induced Liver Injury in Mice
Hiroshi K	-	Fatal Hemorrhagic Disorder and Vascular Intimal Carcinomatosis in Annexin II Expressing Transitional Cell Carcinoma
Hiroshi S	-	Diagnosis of Deep Vein Thrombosis by Soluble Fibrin or D-dimer
Hiroshi Shiku	-	High Mobility Group Box Protein Is Increased in the Plasma and May Have a Role in Development of Organ Failure in DIC
Hirschfield G	-	In Patients with the Biphasic Waveform, Lipoprotein Complexation Does Not Retard C-Reactive Protein Induced Complement Activation
Hirschl M	-	Prediction of the Risk of Recurrent Venous Thromboembolism by the Activated Partial Thromboplastin Time
	-	Risk Factors for the Postthrombotic Syndrome (PTS)
	-	A Positive Family History of Venous Thromboembolism Does Not Predict A High Risk of Recurrence
	-	C-Reactive Protein 3'UTR (+1444) C>T Polymorphism in Patients with Spontaneous Venous Thromboembolism
	-	Tissue Factor Pathway Inhibitor and the Risk of Recurrent Venous Thromboembolism (VTE)
Hirsh J	-	Heparin Levels with Subcutaneously (sc) Low-Molecular-Weight-Heparin (LMWH) and Unfractionated Heparin (UFH): Results from a Randomized Trial
	-	Acute Treatment of Venous Thromboembolism (VTE) with Fixed-Dose, Weight-Adjusted, Unfractionated Heparin (UFH) Given Subcutaneously (sc) without Laboratory Monitoring: Randomized Comparison with Low-Molecular-Weight-Heparin (LMWH)
Hitos K	-	Prevalence of Deep Vein Thrombosis in Trauma: A Prospective Study of Orthopaedic Trauma Patients in Tianjin Hospital, China
	-	Effect of Leg Exercises on Popliteal Venous Blood Flow During Prolonged Immobility of Seated Subjects: Implications for Prevention of Travel Related Deep Vein Thrombosis
	-	Venous Thromboembolism and Spinal Surgery
Hitos K	-	Venous Thromboembolism Following Total Hip or Knee Arthroplasty
Hjemdahl P	-	Postprandial Hyperglycaemia Induces Platelet Activation in Type 2 Diabetes Mellitus: Effects of Treatment with Repaglinide and Glibenclamide
	-	Contrast Medium Attenuates Platelet Activation and Platelet-Leukocyte Cross-Talk
	-	Effects of Acute Hyperglycaemia on Platelet and Leukocyte Activation: Involvement of Multiple Mechanisms
	-	Food Intake Enhances Platelet Reactivity to Thromboxane in Type 2 Diabetic Patients
Hjemdahl P	-	Inhibition of the Renin-Angiotensin System Does Not Reduce Platelet Activity at Rest or during Stress in Essential Hypertension
Hjemdahl P	-	Effects of Oral Hormone Replacement Therapy (HRT) on Platelet Function, Inflammatory Markers and Matrix Metalloproteinases in Postmenopausal Women with Established Coronary Artery Disease
	-	Effects of Improved Metabolic Control on Platelet Reactivity in Patients with Type 2 Diabetes Mellitus Following Coronary Angioplasty
	-	Platelet-Lymphocyte Conjugation: Different Behavior Between T and B Cells
Hjortoe GM	-	Factor VIIa Binding and Internalization in Hepatocytes
Hlusi A	-	Determination of Platelet Derived Microparticles in Patients with Autoimmune Thrombocytopenia (AITP)
Hlusi A	-	Clinical Phenotype of Hemophilia and Prothrombotic Gene Mutation
Hmaguchi M	-	In vitro Characterization of Two Missense Mutations Associated with Quantitative Protein S Deficiency
Ho PL	-	Identification of New Secreted Proteins from Haementeria Depressa Leech Salivary Complexes by Transcriptomic and Proteomic Analysis
	-	Amblyomma Cajennense Tick: The Transcriptome, Expression and Biochemical Characterization of a Factor Xa Recombinant Inhibitor
Ho S-J	-	Autoimmune Thrombocytopenia
Ho P	-	Effects of Leptospiral Proteins on Human Endothelial Cells
Hobbs JE	-	Tissue Factor: Lack of the Cytoplasmic Tail Results in Generation of Functional Microparticle-Associated Tissue Factor
Hockman S	-	The Importance of PDE3A in the Regulation of Platelet Aggregation
Hod H	-	High Rate of Unresponsiveness to Clopidogrel in Patients with Acute Coronary Syndrome (ACS) As Determined by the Impact-R [Cone And Plate(let) Analyzer]
	-	Statins Confer a Direct Anti-Platelet Effect in Patients with Acute Myocardial Infarction Treated with Aspirin and Clopidrogel: Ex-vivo and in-vitro Study Results
Hoefelmann C	-	Inhibition of Thrombosis after Vascular Injury with a Novel Tissue Factor-Targeted Thrombomodulin Fusion Protein
Hoegee-de Nobel E	-	Development of a New Test for the Global Fibrinolytic Capacity in Blood
Hoek FJ	-	The Phospholipid Composition of Cell-derived Microparticles Changes in the Postprandial State
Hoekstra JBL	-	Acute Hyperglycemia Perturbs Endothelial Glycocalyx and Induces a Prothrombotic State in Healthy Volunteers
Hoekstra MMCL	-	Preanalytical Variables and Off-Site Blood Collection: Influences on the Results of the Prothrombin Time/International Normalized Ratio Test and Implications for Monitoring of Oral Anticoagulant Therapy
Hoffer L	-	Viral Safety of a Prothrombin Complex Concentrate (Octaplex^®): Combination of Solvent/Detergent (SD) Treatment with Nanofiltration
Hoffer L	-	Consistent Manufacturing of 50 Consecutive Octaplex^® 500 Lots: Biochemical Characteristics of a Prothrombin Complex Concentrate
Hoffman EP	-	Decreased Platelet Expression of MYL9 (Myosin Light Chain Regulatory Polypeptide) and Other Genes with Platelet Dysfunction and CBFA2 (AML1) Mutation: Insights From Platelet Expression Profiling
Hoffman M	-	Hemophilia B Mice Have Delayed Wound Healing
	-	Reaction of Fibrinogen with Homocysteine Thiolactone Renders the Resulting Fibrin Clots Resistant to Lysis
	-	Characterization of a Novel Recombinant Factor VIIa Analog in a Cell-Based Model of Coagulation
	-	Cell-Based Models of Haemostasis
Hoffmann JN	-	Heparin Abrogates the Positive Effect of High-dose Antithrombin III in Severe Sepsis (KyberSept Study)
Hoffmann D	-	In Silico Design and in Vitro Validation of a Mimotope for Blocking a FVIII-inhibitor Antibody ESH8
Hoffmann U	-	Drotregocin Alfa (Activated) Down-Regulates RANTES in Peripheral Blood Mononuclear Cells of Septic Patients In Vivo
Hoffmann C	-	Glykoprotein VI Mediates Platelet Adhesion to Vulnerable Human Atherosclerotic Plaque
Hoffmeister KM	-	Galactosylation of GPIba by an Externally Active Endogenous b4Galactosyl Trasferase Prolongs Platelet Survival
Hofmann H	-	Superparamagnetic Iron Oxide Uptake as Imaged By Magnetic Resonance Is Mediated by the Integrin Receptor MAC-1 (CD11b/CD18) – Possible Implications on Imaging of Atherosclerotic Plaques
Hofstra L	-	Annexin A5 Regulates the Engulfment Protein Repertoire on the Membrane of PS Expressing Apoptotic Cells
	-	Down-regulation of Tissue Factor Surface Expression by Annexin A5: a New Anticoagulant Mechanism
	-	Real-Time in Vivo Imaging of the Kinetics of Macrovascular Thrombus Formation
Hogg K	-	PIOPED Ventilation-perfusion Scan Reporting: The Inter-observer Variation
	-	Retrospective Calculation of the Modified Wells' Clinical Probability of Pulmonary Embolism: Agreement with Prospective Scoring
Hogg PJ	-	Mechanism of Activation of Tissue Factor
Hogg PJ	-	Thrombospondin as a Regulator of von Willebrand Factor Multimer Size
Hogwood J	-	Protamine Sulphate Neutralization of Anti-Xa and APTT Activities of Low Molecular Weight Heparin Oligosaccharides
	-	Cardiovascular Risk Factors Contributing to Endogenous Thrombin Potential (ETP) in Type 2 Diabetes
Hogwood J	-	Measurements of Soluble Thrombomodulin Activity and Antigen: Factors Contributing to Variance and Potential for Identification of Protein Variants
Hohensinner PJ	-	Cardiac Myocytes and Cardiac Fibroblasts Are Actively Involved in the Recruitment of Monocytes
Hohm T	-	In Silico Design and in Vitro Validation of a Mimotope for Blocking a FVIII-inhibitor Antibody ESH8
Höijer P	-	Thromboembolic Complications in 16 Patients Undergoing Free Flap Surgery
Hoke M	-	Tissue Factor Pathway Inhibitor and the Risk of Recurrent Venous Thromboembolism (VTE)
Holanda RARR	-	Incidence of Factor VIII Inhibitor in Hemophilia ‘A’ in Ceara – Brazil
Holbova R	-	Evaluation of Pro-Angiogenic Activity of Factor XIII (FXIII) in Murine Models of Heart Transplantation and FXIII-Deficient Mice
Holdsworth SR	-	Anti-Neutrophil Cytoplasmic Antibodies (ANCAs) Promote Leukocyte Adhesion in the Glomerular Microvasculature
Holler E	-	Defibrotide and Oligotide, Two DNA-Based Drugs, Protect Human Microvascular Endothelial Cells against Chemotherapy-Induced Damage and Activation
Hollý P	-	Beta-Thromboglobulin, Platelet Factor 4 and Soluble P-Selectin in Hemodialysis Patients with EPO Therapy
	-	Plasma TFPI Levels in Patients Undergoing Regular Hemodialysis and Treated with Erythropoietin
Holm JP	-	Reduction of Fetal Loss Rate by Anticoagulant Treatment during Pregnancy in Women with Hereditary Deficiency of Antithrombin, Protein C or Protein S Type I. A Prospective Study
	-	Fetal Loss in Hereditary Antithrombin, Protein C and Protein S Deficiencies
Holmberg L	-	Responsiveness to Desmopressin: Influence of Genotype in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD
	-	Abnormal Multimeric Pattern Is Not Associated with Increased Bleeding Symptoms in Index Cases of Families with Type 1 VWD. Results from the EU MCMDM-1 VWD Study
	-	Cysteine Mutations in the von Willebrand Factor D3 Domain Correlate with Multimerization Defects in Patients Previously Diagnosed with von Willebrand Disease Type 1 in Patients Entered in the European Multicentre Study MCMDM-1VWD
	-	Expression of ADAMTS13 in Normal Renal Cortex and in Thrombotic Thrombocytopenic Purpura
	-	Mutation Profile in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
	-	Linkage Analysis of von Willebrand Disease Type 1 Phenotype, von Willebrand Factor Levels and Bleeding Symptoms with Von Willebrand Factor Gene Locus in the European Multicenter MCMDM-1VWD Study
	-	Collagen Binding (VWF : CB) Is Less Sensitive Than Ristocetin Cofactor Activity (VWF : RCo) in Suggesting Von Willebrand Factor (VWF) Molecular Defects in Patients with Von Willebrand Disease Type 1: Results From the European Multicenter MCMDM-1VWD Study
	-	Analysis of Bleeding Score in Type 1 VWD Families in the MCMDM-1 Study
	-	Assay of the von Willebrand Factor Propeptide (VWFpp) to Identify Type 1 von Willebrand Disease (VWD) Patients with a Decreased von Willebrand Factor (VWF) Survival Phenotype
	-	The Factor VIII/von Willebrand Factor Antigen (FVIII/VWF : Ag) Ratio in Determining VWF Defects in Patients with von Willebrand Disease Type 1: Results from the European Multicenter MCMDM-1VWD Study
	-	The Incidence and Penetrance of Common VWF Gene Mutations in a Cohort of Type 1 VWD Patients: Results from the EU Funded MCMDM-1VWD Project
	-	In vitro Expression of Ten Missense Mutations in the VWF C-Terminal Domain Identified in Patients Diagnosed with Type 1 VWD: Results from the MCMDM-1VWD Study
	-	Association of FVIII/Von Willebrand Factor Measurements and PFA-100® with Bleeding Score in Type 1 Von Willebrand Disease (VWD) Families. The MCMDM-1 Study
	-	Cys570Ser Mutation in the von Willebrand Factor Propeptide in Recessive von Willebrand Disease
	-	Multimer Pattern in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
	-	A Reduced VWF to FVIII Binding Capacity is not Uncommon in Patients With Type 1 Von Willebrand Disease: Results From the MCMDM-1VWD Study
	-	Two Novel Type 1 Von Willebrand Disease Causing Mutations (G160W and N166I) in the Von Willebrand Factor Propeptide, Identified in the European Study MCMDM-1VWD, Are Responsible for Multimerization And Secretion Defects
Holmen J	-	Anticardiolipin Antibodies and Risk for Venous Thrombosis in a Population-Based Prospective Study
Holmen LO	-	A Fast Track Strategy for Managing Suspected Pulmonary Embolism (PE) in Outpatients
Holmström M	-	Prospective Evaluation of Low PAI-1 Activity as a Risk Factor for Hemorrhagic Diathesis
	-	Supplementation with Folic Acid or Vitamin C and E in Patients with Bleeding Disorders and Hepatitis C Treated with Pegylated Interferon and Ribavirin
	-	Experience of Surgery with Continuous Infusion at Karolinska University Hospital in Patients With Hemophilia A and B, von Willebrand'S Disease and FVII-Deficiency
	-	Treatment of Chronic Hepatitis C Infection in Patients with Hemophilia or Von Willebrand Disease with a Combination of Pegylated Interferon and Ribavirin
	-	Long-term Prophylaxis in VWD. The Swedish Experience
Holyoake AJ	-	A New Form of Familial Thrombocytopenia Associated with a Mutation of Cytochrome C
Holzhauer S	-	Platelet CD40L in Chorioamnionitis
Homeister J	-	Additional Environmental and Genetic Factors Are Required to Trigger TTP in ADAMTS13-Deficient Mice
Honda S	-	Generation and Characterization of ADAMTS13-Deficient Mice
	-	Identification of Genetic Variations in Genes Comprised in Vitamin K-dependent g-Carboxylation System
Honda Y	-	Antithrombotic Properties of DU-176b, a Novel Orally Active Factor Xa Inhibitor: Inhibition of both Arterial and Venous Thrombosis, and Combination Effects with Other Antithrombotic Agents
Honda S	-	Enhanced Platelet Aggregation and Thrombogenic Tendency in Adiponectin-Deficient Mice
Honda Y	-	Pharmacological Characterization, Antithrombotic and Bleeding Effects of DU-176b, a Novel, Potent and Orally Active Direct Inhibitor of Factor Xa: A Wider Safety Margin of Antithrombotic and Bleeding Effects Compared to Heparin, LMWH and Warfarin
	-	Recombinant Factor VIIa Reverses Te Prolonged Bleeding Time Induced B A High Dose of DU-176b, a Novel Direct Factor Xa inhibitor, In Rats
	-	Antithrombotic Effects of a Direct Factor Xa Inhibitor, DU-176b, and an Antithrombin Dependent Factor Xa Inhibitor, Fondaparinux, on an Ex vivo Capillary Perfusion Chamber Thrombosis Model in Rats
Hong JT	-	Inhibitory Effect of Luteolin on the PDGF-Induced Proliferation of Rat Aortic Vascular Smooth Muscle Cells
Hong T	-	Thrombophilia, Placental Pathology and Perinatal Cerebral Infarction: Any Relationship?
Hongli W	-	Novel Aberrant Splicings Caused by a Splice Site Mutation IVS1a+5g > a in F7 Gene
Hönig M	-	Severe Bleeding Caused by a Platelet Defect Leading to Enhanced Binding of Coagulation Factor XI (FXI) to Platelet GPIb-alpha
Honnart D	-	Are Diagnostic Algorithms for Suspected Pulmonary Embolism Applicable in French Emergency Departments?
Hoogsteden H	-	Non-Invasive Diagnosis of Pulmonary Embolism Anno 2005
Hook CC	-	Rituximab Treatment of FVIII Inhibitors in Congenital Hemophilia A (cHA)
Hooper WC	-	Sickle-cell Trait and the Risk of Venous Thromboembolism
	-	The CXCL 16 Chemokine Is Induced by Angiotensin II in the U-937 Human Monocytic-Derived Cell Line
Hooper WC	-	The Relationship of the GAS6 Gene to Myocardial Infarction in African-Americans and Caucasians
	-	The Relationship Between Genetic Variants in the Endothelial Protein C Receptor and Venous Thromboembolism
Hooper WC	-	Associations of Factor VIII (FVIII) and von Willebrand Factor Antigen (VWF:Ag) with Race, Age, ABO Blood Group and Co-Morbid Conditions
Hooper W	-	The Association Between Diabetes and Venous Thromboembolism in African Americans and Caucasians and the Relationship with Peroxisome Proliferator-Activated Receptor Polymophisms
Hoppe CC	-	Is the Novel Genetic Mutation, Prothrombin C20209T, an Independent Risk Factor for Stroke among African-Americans with Sickle Cell Anemia?
Hoppe K	-	In vivo Relevance of Platelets and the Fibrinogen Receptor GPIIb-IIIa for Experimental Melanoma Metastasis
Hoppener MR	-	Sustained Factor VIII and vWF Elevation after Total Hip Arthroplasty
	-	Incidence of Deep Vein Thrombosis after Knee Arthroscopy without Thromboprophylaxis
	-	The Incidence of Venographically Detected Deep Vein Thrombosis after Knee Arthroscopy without Thromboprophylaxis
Hoppensteadt D	-	Antithrombotic Effects of Bacterial K5-Derived Sulfaminoheparosans in a Jugular Vein Crush Model of Thrombosis in Rats
	-	Evaluation of the Anticoagulant Effect of Enoxaparin by Using Clot Based Point of Care Tests
	-	Antithrombotic Mechanism of Action of BAY 59-7939 – a Novel, Oral, Direct Factor Xa Inhibitor
	-	Betaine, a Novel Anticoagulant with Combined Nitric Oxide and Tissue Factor Pathway Release Potential. Implications in the Management of Peripheral Vascular Diseases
	-	Functional Decrease in Thrombin Activatable fibrinolytic Inhibitor by Anticoagulant Drugs: A Possible Explanation for the Observed Profibrinolytic Actions
	-	Inhibition of Tissue Factor Mediated Protease Activation by Mucosopolysaccharide Polysulfate. Results from Studies on Proteinchip Array Using SELDI-MS
	-	Modulation of Inflammatory Markers after Treatment with Topically Administered Mucopolysaccharide Polysulfate. Results of a Study in Primates
	-	Tissue Factor Mediated Activation of Prothrombin Complex Concentrates and Its Inhibition by Anti-Thrombin Drugs
	-	Development of Non-Anticoagulant Derivatives of K5-Derived Sulfaminoheparosans and Investigation of Their Non-Anticoagulant Effects
Hoppensteadt D	-	Comparison of the Anticoagulant Properties of BAY 59-7939 – An Oral, Direct Factor Xa Inhibitor – with Fondaparinux and Enoxaparin
Hoppensteadt D	-	Nitric Oxide Generation During Parenteral Administration Differentiates Argatroban from Lepirudin and Bivalirudin
	-	Elevated Nitric Oxide Levels with Brachytherapy Compared to Bare Metal or Sirolimus Eluting Stents. Implications in Coronary Restenosis
Hoppensteadt D	-	Laboratory and Clinical Validation of a New Functional, Plasma-Based Assay for the Detection of Factor V Leiden: the Pefakit^® APC-R Factor V Leiden Assay
Hoppensteadt D	-	Protamine Sulfate Is Capable of Neutralizing Bacterial Core Polysaccharide Derived Sulfaminoheparosans
Hoppensteadt D	-	Cross Validation of the 2^nd International Standard of Low Molecular Weight Heparin (IS 2003–01/608) in the Anti-Xa, Anti-Iia Heptest and PiCT Tests
Hoppensteadt D	-	Differential Modulation of Thrombin Activatable Fibrinolytic Inhibitor by Unfractionated Heparin
	-	Effect of GpIIb-IIIa on the Point of Care Coagulation Tests in Patients Undergoing Percutaneous Coronary Intervention (PCI)
	-	Differential Digestion of LMWHs By Heparinase-I and Heparinase-II: Drug Developmental Implications
	-	Tissue Factor, Thrombomodulin and P-Selectin Levels Are Increased in End Stage Renal Disease
Hoppensteadt D	-	Interaction of BAY 59-7939 – A Novel, Oral, Direct Factor Xa Inhibitor – with Antiplatelet Agents: Monitoring and Therapeutic Applications
Hoppensteadt D	-	Upregulation of Inflammatory Mediators in ESRD Patients: Pathophysiologic Implications
Hoppensteadt DA	-	Effect of 1,6-Anhydro Bicyclic Ring Structure on the Pharmacokinetic and Pharmacodynamic Behavior of Low Molecular Weight Heparin
Hoppensteadt D	-	Comparative Anticoagulant Effects of a Synthetic, Dual Antithrombotic/Antiplatelet Agent, CanAm 208, with Argatroban and Angiomax
	-	Comparative Antithrombotic Effects of an Ultra Low Molecular Wight Heparin (Oligo H) and Enoxaparin in Animal Models of Arterial Thrombosis
	-	Proteomic Profiles in Critically Ill Emergency Department Patients, Utilizing ProteinChip Array Technology
	-	Down-Regulation of Inflammatory Markers after Treatment with Topically Administered Mucopolysaccharide Polysulfate in Primates
	-	Biochemical and Pharmacological Equivalence of Generic Versions of Low Molecular Weight Heparins. A Comparative Study with Innovator Products
	-	Nitric Oxide Levels Are Elevated in Patients with Malignancy Associated Hypercoagulable State
	-	Comparative Study on the Anticoagulant Effects of Low Molecular Weight Heparins As Measured by Whole Blood ACT, Anti-Xa and a Newly Developed Prothrombinase Induced Clotting Time (PiCT) Assay
	-	Hyperhomocysteinemia in Cancer Patients with Thrombosis Is Not Associated with Methylene Tetrahydrofolate Reductase (MTHFR) Gene Mutations and Can Be Down Regulated by Low Molecular Weight Heparin Treatment
	-	Enoxaparin (E) and Warfarin (W) Differentially Regulate Tissue Factor (TF), Tissue Factor Pathway Inhibitor (TFPI) and Thrombin Activatable Fibrinolytic Inhibitor (TAFI) in Cancer Patients with Thrombosis
Hoppensteadt D	-	Biochemical and Pharmacologic Profiling of a Novel Dual Acting Antithrombin Agent with Antiprotease and Antiplatelet Actions
	-	Ex vivo Evaluation of the Pharmacodynamic Effects of Defibrotide. Results from Various Clinical Trials
Hoppensteadt D	-	Protein Chip Array Profiles in End Stage Renal Disease (ESRD) Patients
	-	Synthetic Anti-Xa Drugs but not Fondaparinux Can Be Used for Surgical and Interventional Anticoagulation
Horák J	-	Changes of Coagulation after Single i.v. Bolus 0.75 mg Per kg of Low Molecular Weight Heparin Enoxaparin During PCI – A Pharmacokinetic Study
Horellou MH	-	Risk of Venous Thromboembolism (VTE) Related to first Pregnancy in At-Deficient Women. One-Center Study of 43 Pregnant Women without Prophylaxis
	-	Pregnancy-associated Venous Thrombosis (VTE) in Women with Hereditary Heterozygous Factor V Leiden or Factor II 20210A Gene Mutation or Both
	-	Retrospective Study of 41 Patients Homozygous for the Prothrombin G20210A Mutation
	-	Pregnancy-Associated Venous Thrombosis (VTE) in Women with Hereditary Heterozygous Factor V Leiden or Factor II 20210A Gene Mutation or Both
	-	Influence of Fondaparinux on INR Expression in Patients Receiving Oral Vitamin K Antagonists
	-	A Mutation in Vitamin K Epoxide Reductase Complex Subunit-1 (VKORC1) in a Patient with Vitamin K Antagonist Resistance
	-	Atypical Mutations of the Prothrombin Gene Located at 20209, 20218 and 20219 Position: A Report of 10 Patients with Venous Thromboembolism History
Horellou MH	-	Fibrinogen Paris IX: A Case of Symptomatic Hypofibrinogenaemia Associated With Bbeta Y236C and Bbeta IVS7 -1G > C Mutations
Hori Y	-	Platelet Thrombus Formation in Blood Vessel-Mimicking Microchannel
	-	Evaluation of Shape Change in Chilled Blood Platelet Using Light Scattering
Horie S	-	Thrombomodulin Inhibits Tumor Cell Invasion Through Three Different Domains of the Molecule
	-	Circadian Clock Genes are Involved in the Regulation of fibrinolytic Activities in Mice
Horie S	-	Circadian Oscillation of Thrombomodulin Gene Expression in Peripheral Tissues
Horn M	-	Prothrombotic Tendency upon Inflammatory Conditions – Alpha Defensins (HNP-1/2/3) Are Strong Platelet Agonists
Horn A	-	Prolonged Thromboprophylaxis with Dalteparin May Improve Survival in Patients Operated on for Abdominal Cancer
Horn E	-	36 Novel Factor VIII Mutations in the Scottish Hemophilia a Population
Horn M	-	New Function for Protease Inhibitors – Alpha1 Antitrypsin and Antithrombin III Inhibit the Activation of Platelets by Alpha Defensins from Neutrophils
Horstman L	-	Interstitial Pulmonary Lesions in Patients with Recurring Severe ITP
Horstman LL	-	Endothelial Microparticle Binding to Neutrophils Is an Important Determinant of Neutrophil Activation In Vivo in Different Clinical Conditions
Horstman L	-	Antiphospholipid Antibodies and Platelet Activation as Thrombotic Risk Factors in Thrombocythemia Associated with Myeloproliferative Disorder
	-	ITP Developing in Spouses of Patients with Chronic ITP: ‘Spousal ITP’
Horter S	-	Rotation Thromboelastometry in Patients Receiving Platelet Transfusion after Chemotherapy
Horton S	-	Tissue Factor Pathway Inhibitor (TFPI) during Cardiopulmonary Bypass (CPB) in Children
	-	Monitoring Haemostasis in Cardiopulmonary Bypass in Children – Measures of Heparin Activity
	-	Platelet Changes during Cardiopulmonary Bypass in Children
Horvath A	-	Use of the D-Dimer for Exclusion of VTE: Difficulties Revealed through the Proficiency Testing Program of the College of American Pathologists (CAP)
Horvathova D	-	Heterozygosity for a Novel FGG Trp253Cys Mutation Causes Hypofibrinogenemia by Specifically Impairing Fibrinogen Secretion
	-	Genetic and Phenotypic Analysis of Families with Inherited Hypo- and Dys-fibrinogenemia
Hosch S	-	Platelet Activation Markers and Procoagulant Phenotype of Monocytes do Correlate with Markers of Reperfusion Injury Following Reperfusion after Orthotopic Liver Transplantation
Hoshiba Y	-	Detection of von Willebrand Factor and Tissue Factor in Platelets-Fibrin Rich Coronary Thrombi Causing Acute Myocardial Infarction
Hoshino H	-	A Prospective Comparison of New Japanese Criteria for Disseminated Intravascular Coagulation. New Japanese Criteria vs. ISTH Criteria
Hosokawa K	-	Anticoagulant and Antiplatelet Thrombin Derivative That Differentiates Macromolecular Substrates of Thrombin
Hotamisligil GS	-	Auto-Amplification of TNF-Alpha: A Potential Mechanism for the Maintenance of Elevated TNF-Alpha in Male But Not Female Obese Mice
Houben B	-	Changes in Fibrinolysis Activity after Angiotensin II Receptor Blockade in Patients Undergoing Renal Artery Angiography
Hough C	-	Understanding the Genotype/Phenotype Link in Type 1 von Willebrand Disease (VWD): Results from The Canadian Type 1 VWD Study
	-	Characterization of Recombinant Canine Factor VIII and Quantitative Determination of Factor VIII in Canine Plasma
	-	A Pilot Study of a DNA Microarray-Based Approach for the Screening of Mutations in Hemophilia A
	-	Anti-FVIII Inhibitor Development in Hemophilic Mice is Dependent Upon Genetic Background, Adjuvant Type, Injection Site, and Frequency of Antigen Exposure
	-	Prevention of Anti-FVIII-C2 inhibitor formation Post Protein infusion in Hemophilic Mice By Prior Oral and/or Nasal Exposure of the FVIII-C2 Domain
	-	The Mutational Spectrum of Type 1 Von Willebrand Disease (VWD): Results from the Canadian Type 1 VWD Study
Houng A	-	Pro-Fibrinolytic Monoclonal Antibodies That Convert a2-Antiplasmin from a Plasmin Inhibitor to a Substrate
	-	Proteolysis of Streptokinase during Plasminogen Activation Regulates the Potency and Specificity of Fibrinolysis
Housman DE	-	CalDAG-GEFI and Protein Kinase C (PKC) Represent Alternative Pathways Leading to Activation of Integrin aIIbb3 in Platelets
Houston DS	-	Shortcomings of the Activated Partial Thromboplastin Time (aPTT) As a Routine Screening Test of Hemostasis
	-	Pilot Study of a New Hemostasis Screening Test (HST) Developed by Modification of the Activated Partial Thromboplastin Time (aPTT)
	-	An Unusual Factor VIII Inhibitor Developing in a Patient with Mild Hemophilia A
Houwing-Duistermaat JJ	-	Haplotypes of the Fibrinogen Genes, Plasma Fibrinogen Levels and the Risk of Deep Venous Thrombosis
Hovens MMC	-	Resolution of Pulmonary Thrombo-embolism in Patients with Pulmonary Embolism; A Systematic Review
Hovy L	-	Evaluation of Thrombotic Events in Haemophiliacs Undergoing Major Orthopaedic Surgery without Thrombosis Prophylaxis
Howard TE	-	The Pharmacogenetics and Inhibitor Risk (PIR) Study: Do the Multiple Forms of Wildtype Factor (F)VIII Contribute to the Development of Anti-FVIII Antibodies in Hemophilia a Patients during Coagulation Factor Replacement Therapy?
Howard I	-	Cocoa Beverage Shows Platelet Inhibition Activity, Depressing Platelet Activation Antigens CD61, CD62p and PAC1 and Extending the PFA 100 Closure Time
Howarth DJ	-	Risk Factors for Central Retinal Vein Occlusion
Howarth N	-	Multi-detector Row Computed Tomography in Outpatients with Suspected Pulmonary Embolism
Howarth DJ	-	Persistent Hypercoagulability and Risk of Cancer in Older Men
Howe B	-	Independent QA Exercise to Validate INR Test Strip Performance and Evaluate Perceptions of Excess Test Strip Error Messages in Support of the THINRS Trial
	-	Independent Qa Exercise to Validate Poc Coagulometer Reliability in Support of the Thinrs Trial and to Allay Perceptions of Possible Coagulometer Dysfunction
Howes J-M	-	A Proteomics Approach for the Identification of Plasma Transglutaminase (FXIII) Substrates
	-	Characterizing the Plasma Clot Proteome
Hoylaerts MF	-	Macrophage-neutrophil Cross Talk During Pulmonary Exposure to Silica Particles Triggers Peripheral Platelet Activation Via Elastase
	-	Impaired Platelet Adhesion on Collagen Surfaces and Secretion Defect in Duchenne Muscular Dystrophy Patients
	-	Crosstalk Between Integrins a2b1 and aIIbb3 during Platelet Activation
	-	Non-helical Peptide Sequence SRHPRVGVYHVFDSA Binds Specifically to Human Integrin a2b1
	-	Domain A1 in Unfolded von Willebrand Factor Can Recruit Flowing Platelets to Collagen Surfaces Independently of Domain A3
	-	Activation and Translocation of Tyrosine Phosphatase SHP-1 to Lipid Rafts Is P2X1 Mediated: Role in Collagen Induced Platelet Activation
Hoylaerts M	-	Plasma Ecto-NTPDase Prevents Platelet P2X₁ and P2Y₁₂ Receptor Desensitization During Storage
Hoylaerts MF	-	P-selectin Antagonist Gallic Acid is Antithrombotic Via Inhibition of Circulating Tissue Factor Deposition in Developing Murine Arterial Thrombi
	-	Thrombospondin-1 Secures Thrombus Adherence in vivo by Protecting (Sub)Endothelial VWF from Leavage by ADAMTS13
	-	NF279 Inhibits the Contribution of P2X₁ to Arteriolar Thrombosis Via Partial Agonism
Hrachovinová I	-	A Multicentre Study on 50 Cases with Thrombotic Thrombocytopenic Purpura in the Czech Republic: Recurrent Mutation in ADAMTS13 Gene as a Cause of a Hereditary Thrombotic Thrombocytopenic Purpura
Hrachovinová I	-	Project HemIS (Haemophilia – Information System): Multicentric Information System of Patients with Haemophilia
Hrafnkelsdottir T	-	Proinflammatory Cytokines Impair Endothelial Fibrinolytic Capacity Partly Independently of NFkB
Hérault J-P	-	VEGF-R2 and Neuropilin-1 Are Involved in VEGF-A-Induced Differenciation of Human Bone Marrow Progenitor Cells
Hristov D	-	Implantation of Total Hip Prosthesis in a Hemophilic Patient – Is Antithrombotyc Prophylaxis Necessary?
Hron G	-	A Positive Family History of Venous Thromboembolism Does Not Predict A High Risk of Recurrence
	-	The Association Between Tissue Factor-Exposing Microparticles and the Activation of the Coagulation System in Cancer Patients
	-	Prediction of the Risk of Recurrent Venous Thromboembolism by the Activated Partial Thromboplastin Time
Hron G	-	Venous Thromboembolism in Inflammatory Bowel Disease: The Pathogenetic Role of Tissue Factor Exposing Microparticles
Hársfalvi J	-	Comparison of Platelet Deposition on Collagen in Cone-And-Plate and Parallel Plate Flow Chambers
	-	Time Dependent Increase in Thrombus Size Formed under Flow Conditions upon Exposure to Collagen Correlates Inversely with Surface Expressed VWF
	-	Evidence That the Holes in Immobilized Fibrinogen Are Always Available
Hryszko T	-	Protein S Suppresses Invasive Potential of THP-1 Cells by Lowering Binding Capacity of Plasminogen on Cell Surface
Hryszko T	-	Hepcidin: A Link between Anemia, Inflammation and Liver Function in HD Patients?
Hsiao G	-	Inhibitory Effects of Andrographolide on LPS-Induced Tissue Factor Expression in Human Monocytic THP-1 Cells
Hsu M-Y	-	Evidence for the Anit-thrombotic Efficacy of Potato Carboxypeptidase Inhibitor in a Mouse Model of Ferric Chloride-Induced Venous Thrombosis
Hsu CC	-	A Snake Venom Metalloproteinase, Kistomin, Cleaves Platelet Glycoprotein VI to Disrupt Platelet Function
Hsu T-C	-	Severe Hemophilia B Due to a 6 kb Deletion Including Exon 4, Due to Non-Homologous Recombination and Associated with Dysfunctional Protein Missing the First EGF-like Domain
Hu L	-	Clearance of Plasminogen Activator Inhibitor-1 in Low-Density Lipoprotein Receptor-Related Protein Deficient Mice
Hu YQ	-	Genetic Analysis of Chinese Patients with Inherited Afibrinogenemia
Hu H	-	Activation and Translocation of Tyrosine Phosphatase SHP-1 to Lipid Rafts Is P2X1 Mediated: Role in Collagen Induced Platelet Activation
Hu X	-	Caveolin-1 Expression Regulates Cell Surface Exposure and Anticoagulant Function of Tissue Factor Pathway Inhibitor
Hu X-H	-	The Clinical Significance of Matrix Metalloproteinases Production by Bone Marrow Mononuclear Cells from Patients with Chronic Myeloid Leukemia
Hu H	-	NF279 Inhibits the Contribution of P2X₁ to Arteriolar Thrombosis Via Partial Agonism
Hu X	-	Clinical Relevance of Expression of VEGF-C and Its Receptors in Patients with Chronic Myelogenous Leukemia
	-	Clinical Relevance of Expression of VEGF-C and Its Receptors IN Patients with Chronic Myelogenous Leukemia
Hu H	-	Glycoprotein IIb/IIIa Blockade Inhibits Platelet Phosphatidylserine Exposure But Not Vesiculation
	-	Acquired Risk Factors Play a Major Role in Venous Thrombosis in Chinese Population
Huan W-M	-	Alteration of Protein Z in Patients with Uremia and Its Significance
Huan X-M	-	Alteration of Protein Z in Cardio-Cerebra Thrombotic Diseases and Its Significance
Huang CL	-	Disabled-2 Is a Secreted Anti-adhesive Molecule During Platelet Activation and Aggregation
Huang HC	-	Thrombomodulin Regulates Cell to Cell Junction Formation
Huang CW	-	Thrombomodulin Regulates Cell to Cell Junction Formation
Huang J	-	Study on Hemostatic and Coagulate Variations During Orthotopic Liver Transplantation
Huang X-p	-	Study on Hemostatic and Coagulate Variations During Orthotopic Liver Transplantation
Huang W	-	Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients: Do Perceived Risk Factors for Bleeding Influence Physicians' Practices? Findings From the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE)
Huang Q	-	The Activity of GPG-290, An Antagonist of vWF-mediated Platelet Capture, Can Be Rapidly Monitored Using the PFA-100^™ Assay
Huang R-H	-	Analysis of Free Thiols During Von Willebrand Factor Biosynthesis: Implications for the Oxidoreductase Mechanism of Multimerization
Huang TF	-	A Snake Venom Metalloproteinase, Kistomin, Cleaves Platelet Glycoprotein VI to Disrupt Platelet Function
Huang WZ	-	The Role of Serotonin and Melatonin on Hematopoiesis and Platelet Production
Huang THW	-	Novel Peroxisome Proliferator-Activated Receptor (PPAR)-a Activator Derived from Gynostemma Pentaphyllum and Its Role in Inhibiting Tissue Factor (TF) Expression and Activity
Huang EC	-	Platelets Express Steroidogenic 17b–hydroxysteroid Dehydrogenases: Distinct Profiles Predict the Essential Thrombocythemic Phenotype
Huang TF	-	Differential Effects of a Glycoprotein Ib Binding Protein, Echiquatin, on Platelet Function in vitro and in vivo
Huang X	-	Study on Platelet-Associated Tissue Factor and Its Significance in Thrombotic Diseases
Hubbard GP	-	Platelets Act as Targets for Newly Identified Peripheral Tachykinins
Hubbard AR	-	A Multi-centre Assessment of the Chromogenic Method for Factor VIII:C Estimation in Plasma-derived and Recombinant Concentrates
Hubbs-T D	-	Delayed FPA Release from Homophenotypic Aa 16 H (Fibrinogen Kingsport): Major b Fibrin Epitope Role in Clotting Times and Branching
Hubel E	-	Enrichment of Early Megakaryocyte Progenitors and Their Ex-Vivo Expansion for Transplantation
Huber K	-	Cardiac Myocytes and Cardiac Fibroblasts Are Actively Involved in the Recruitment of Monocytes
	-	Hepatocyte Growth Factor Mediates Induction of PAI-1, Il-6 And Il-8 in Human Adipose Tissue
	-	Complement Component C5a Predicts Future Cardiovascular Events in Patients with Advanced Atherosclerosis
Hueb WA	-	Evaluation of Hemostasis Changes Between Patients Underwent Coronary Artery Bypass Graft (CABG) with and without Cardiopulmonary Bypass. Partial Results of MASS-III Study
Huff JD	-	Isolated Alpha-2 Antiplasmin Deficiency Presenting in a 63 year Old Man
Huff JD	-	Sporadic Occurrence of Warfarin Resistance Secondary to a Val29Leu Mutation In The VKORC1 Protein
Huff JD	-	Production of a Recombinant Peptide Substrate for the Fluorescence Based Assay of ADAMTS13
Hugelier K	-	Protein Profiling of Human Blood Platelets from Young and Aged Individuals
Hughan S	-	A Novel Cytokine Mediated Route of Promoting the Adhesion of Platelets to Endothelial Cell Monolayers
Hughan SC	-	Syk Plays a Critical Role in Signalling Downstream of GPVI and Integrin a_IIbb₃, But Is not Required for Efficient G-Protein Mediated Platelet Activation
	-	Differential Regulation of Phosphorylation of Adapter Proteins Dok2 and Dok1 in Platelets
Hughan S	-	Syk Plays an Essential Role Downstream of The Platelet Rhodocytin Receptor CLEC-2
Hughes T	-	Molecular Pathways for Lymphangiogenesis and Their Role in Human Disease
Hughes P	-	Platelet Activation and Interaction of rFVIIa (NovoSeven®) with COAT Platelets Following Cardiopulmonary Bypass
Hughes Q	-	Hormonal Regulation of the Anticoagulant Protein S
Hughes GRV	-	Perinatal or Fetal Thrombosis in Babies Allowing Detection of the Anti-phospholipid Syndrome in Mothers
Huh HJ	-	IgM Anti-beta2 Glycoprotein I Antibody as Potential Risk Factor of Thrombosis in Patients with Lupus Anticoagulants
Huhle G	-	Drotregocin Alfa (Activated) Down-Regulates RANTES in Peripheral Blood Mononuclear Cells of Septic Patients In Vivo
Huijgen R	-	Sustained Factor VIII and vWF Elevation after Total Hip Arthroplasty
Huisman MV	-	Prevention of Venous Thromboembolism with an Oral, Direct Factor Xa Inhibitor – BAY 59-7939 – in Elective Hip Replacement: A Dose-Ranging Study
Huisman MV	-	Diagnostic Management in Patients with Clinically Suspected Pulmonary Embolism with Clinical Decision Rule, Quantitative D-Dimer Test and Helical Computed Tomography – The Christopher Study
	-	Implication of Local Versus Independent Assessment of Reference Test for Accuracy of a Rapid Point-of Care Quantitative Assay for D-dimer (Cardiac D-dimer) in the Diagnosis of Deep Vein Thrombosis
Huisman MV	-	CRP as a Biochemical Wells Score? A Double Approach (D-Dimer Plus CRP) in the Diagnosis of Deep Vein Thrombosis – Data from the CARDIM Study
	-	Clearance of Plasminogen Activator Inhibitor-1 in Low-Density Lipoprotein Receptor-Related Protein Deficient Mice
	-	The Distribution Of Central, Segmental And Sub-Segmental Pulmonary Emboli In Multi- And Single-Row Helical CT
	-	Resolution of Pulmonary Thrombo-embolism in Patients with Pulmonary Embolism; A Systematic Review
	-	Sensitivity and Specificity of a Rapid Quantitative Point of Care D-Dimer Assay (Cardiac D-dimer) in the Diagnosis of Deep Vein Thrombosis
Huisman MV	-	Right Ventricular Dysfunction and the Pulmonary Obstruction Index Assessed with Helical CT Predict Clinical Outcome During Three-month Follow-up in Patients with Acute Pulmonary Embolism
Huisse MG	-	Enhanced Shear-Induced Platelet Aggregation in Patients Who Experienced Subacute Stent Thrombosis: A Case-Control Study
Huizinga E	-	Determination of Interacting Residues within the VWF A3-Domain and the Antithrombotic Antibody 82D6A3 by Docking, Cocrystallisation and Mutagenesis
Hulett MD	-	Injury-Inducible Yin Yang-1 Inhibits Vascular Smooth Muscle Cell Growth and Intimal Thickening by Repressing p21^WAF1/Cip1 Transcription and Perturbing Cyclin D1-Cdk4-p21^WAF1/Cip1 Assembly
Hull RD	-	Fatal Vascular Outcomes Following Major Orthopedic Surgery
Hulstein JJJ	-	Active Von Willebrand Factor Is present in Plasma of Patients with Von Willebrand Disease Type 2B Or ADAMTS-13 Deficiency
Humphries SE	-	Cardiovascular Risk Factors Contributing to Endogenous Thrombin Potential (ETP) in Type 2 Diabetes
Humphries SE	-	Measurements of Soluble Thrombomodulin Activity and Antigen: Factors Contributing to Variance and Potential for Identification of Protein Variants
Humphries J	-	Adenovirus Urokinase (uPA) Gene Transfection Mediates Monocyte Fibrinolysis
Humphries J	-	Adenovirus-Mediated VEGF Gene Therapy Enhances Venous Thrombus Resolution
	-	Monocyte Recruitment and Increased Urokinase (uPA) Activity are Important for Thrombus Resolution
Humpich M	-	Elevated Factor IX, XI and XII-Activities Are Associated with an Increased Risk for Venous Thrombosis
Humpich M	-	Prevalence and Clinical Significance of Anti-b2-Glycoprotein-I-Antibodies in Patients with Venous Thrombosis
Hunault-Berger M	-	Evolution of Antithrombin (AT) and Fibrinogen (Fg) Levels during Induction Chemotherapy with L-asparaginase (Asp) in Adult Patients with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL). Clinical Outcomes and Use of Coagulation Supportive Treatments: The CAPELAL Study
Hung SH	-	Inactivation of the Human Platelet cGMP-Induced cAMP Phosphodiesterase (PDE3A) by Affinity Labeling of an Octapeptide in the Unique 44 Amino Acid Flexible Loop
Hunt BJ	-	Ex Vivo Studies of the Effect of Lupus Anticoagulant on Heparin Monitoring
Hunt BJ	-	The Use of the Thromboelastograph and Rotem in Monitoring Recombinant Factor VIIa
	-	Putative Prothrombotic Polymorphisms in Patients with Antiphospholipid Antibodies
Hunt J	-	Production and Characterization of a Novel, Recombinantly-modified Plasmin Molecule
Huntington J	-	New Insights into Heparin Binding and Activation of Heparin Cofactor II
Huntington JA	-	Molecular Recognition Mechanisms of Thrombin
Huntscha S	-	Hyperglycemia Induces Loss of the Protective Endothelial Thrombomodulin Protein C System
Huntsman DG	-	Molecular Characterization of a 4.4 Mbp Deletion of the X Chromosome in a Male with Hemophilia B
Hunzelmann N	-	IgE Mediated Anaphylaxis to Factor VIII
Huo J	-	Critical Role of the Age-Related Homeostasis Mechanism in Amelioration of Hemophilia B Leyden: Role of Growth Hormone and Signal Transduction Network
Huppert P	-	Intravenous Leiomyosarcoma Presenting As Iliac Vein Thrombosis
Hurlen M	-	Occult Bleeding During Long-term Treatment with Aspirin, Warfarin, or Both after Myocardial Infarction. A WARIS-II Subgroup Analysis
Hurley BL	-	Oxidative Modification of Low-density Lipoprotein (LDL) and OxLDL/b2GPI Complexes in Patients with Infectious Endocarditis: Possible Role in Aortic Valve Disease
	-	Circulating oxLDL/b2GPI Complexes, Autoantibodies and Intima-media Thickness in Patients with Systemic Lupus Erythematosus: Possible Role in Autoimmune-mediated Atherosclerosis
Hurlstone A	-	An Early-Activated Gene (6A3-5) Implicated in the Control of Vascular Smooth Muscle Cell Functions
Hursting MJ	-	Effects of the Direct Thrombin Inhibitor Argatroban, Demographic Variables, and Platelet Count on Thrombotic Risks in Heparin-Induced Thrombocytopenia
	-	Venous Thromboembolism in Heparin-Treated Patients: How Frequently Is It Associated with Heparin-Induced Thrombocytopenia?
Hurtaud-Roux MF	-	Molecular Basis of MYH9-Related Disorders in a Series of Ten Families
Hutajulu SH	-	Fibrinogen, Plasminogen Activator Inhibitor-1, and Interleukin-6 in Peripheral Arterial Disease of Type 2 Diabetes Patients
Huth-Kühne A	-	Successful Inhibitor-Elimination with Rituximab in Acquired Hemophilia A and a Patient with a Carrier Status for Hemophilia A – Two Case Reports
Huth-Kühne A	-	Home Treatment of Bleeding Episodes in Haemophiliacs With Inhibitors: Cost-Effectiveness of Three on-Demand Strategies in Germany
Huth-Kühne A	-	The EACH Registry: A Prospective European Registry of Acquired Haemophilia (AH)
	-	A Novel Mutation (Asp36Tyr) in the Vitamin K Epoxide Reductase Complex Subunit 1 (VKORC1) Causes Moderately Increased Coumarin Doses
Hutson SM	-	Engineering of a Recombinant Vitamin K-Dependent Gamma-Carboxylation System with Enhanced Gamma-Carboxyglutamic Acid (Gla) Forming Capacity. Evidence for a Functional CXXC RedOx Center in the System
Hutspardol S	-	Spontaneous Subgaleal Hemorrhage in a Girl with Adrenaline Receptor Defect
Hutten BA	-	Endotoxemia Induces Factor VIII-mediated Resistance to Activated Protein C in Healthy Humans
Huugen D	-	A Hypercoagulable State in Myeloperoxidase Deficient Mice
Hvitfeldt Poulsen L	-	Visualization of Dynamic Fibrin Formation from APTT Recordings Reflects More Heterogeneity in Patients with Severe Haemophilia A Than Conventional APTT Values
	-	Visualization of the Continuous APTT Coagulation Signature – Methods and Correlations to Continuous Thrombin Generation
Hyland C	-	Molecular Dissection of Platelet Production Via Random Mutagenesis